<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Vasodilators for women undergoing fertility treatment - Gutarra‐Vilchez, RB - 2018 | Cochrane Library</title> <meta content="Vasodilators for women undergoing fertility treatment - Gutarra‐Vilchez, RB - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010001.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Vasodilators for women undergoing fertility treatment - Gutarra‐Vilchez, RB - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010001.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010001.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Vasodilators for women undergoing fertility treatment" name="citation_title"/> <meta content="Rosa B Gutarra‐Vilchez" name="citation_author"/> <meta content="San Martin de Porres University" name="citation_author_institution"/> <meta content="dragutarra2@gmail.com" name="citation_author_email"/> <meta content="Xavier Bonfill Cosp" name="citation_author"/> <meta content="CIBER Epidemiología y Salud Pública (CIBERESP)" name="citation_author_institution"/> <meta content="Demián Glujovsky" name="citation_author"/> <meta content="CEGYR (Centro de Estudios en Genética y Reproducción)" name="citation_author_institution"/> <meta content="Andres Viteri‐García" name="citation_author"/> <meta content="Universidad Tecnológica Equinoccial" name="citation_author_institution"/> <meta content="Fernando M. Runzer‐Colmenares" name="citation_author"/> <meta content="Faculty of Medicine, Universidad de San Martín de Porres" name="citation_author_institution"/> <meta content="Maria José Martinez‐Zapata" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD010001.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/10/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010001.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010001.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010001.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Embryo Implantation [*drug effects]; Infertility, Female [*therapy]; Live Birth; *Pregnancy Rate; Randomized Controlled Trials as Topic; Vasodilator Agents [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010001.pub3&amp;doi=10.1002/14651858.CD010001.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Xsb6SJyC";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010001\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010001\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","fr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010001.pub3",title:"Vasodilators for women undergoing fertility treatment",firstPublishedDate:"Oct 12, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xsb6SJyC&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010001.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010001.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010001.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010001.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010001.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010001.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010001.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010001.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010001.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010001.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5168 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010001.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-sec-0099"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-sec-0061"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-sec-0093"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/appendices#CD010001-sec-0104"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/table_n/CD010001StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/table_n/CD010001StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Vasodilators for women undergoing fertility treatment</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information#CD010001-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Rosa B Gutarra‐Vilchez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information#CD010001-cr-0003">Xavier Bonfill Cosp</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information#CD010001-cr-0004">Demián Glujovsky</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information#CD010001-cr-0005">Andres Viteri‐García</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information#CD010001-cr-0006">Fernando M. Runzer‐Colmenares</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information#CD010001-cr-0007">Maria José Martinez‐Zapata</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information/en#CD010001-sec-0113">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 October 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010001.pub3">https://doi.org/10.1002/14651858.CD010001.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010001-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010001-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010001-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010001-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010001-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010001-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010001-abs-0001" lang="en"> <section id="CD010001-sec-0001"> <h3 class="title" id="CD010001-sec-0001">Background</h3> <p>The rate of successful pregnancies brought to term has barely increased since the first assisted reproductive technology (ART) technique became available. Vasodilators have been proposed to increase endometrial receptivity, thicken the endometrium, and favour uterine relaxation, all of which could improve uterine receptivity and enhance the chances for successful assisted pregnancy. </p> </section> <section id="CD010001-sec-0002"> <h3 class="title" id="CD010001-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of vasodilators in women undergoing fertility treatment. </p> </section> <section id="CD010001-sec-0003"> <h3 class="title" id="CD010001-sec-0003">Search methods</h3> <p>We searched the following electronic databases, trial registers, and websites: the Cochrane Gynaecology and Fertility Group (CGF) Specialised Register of controlled trials, the Cochrane Central Register of of Controlled Trials, via the Cochrane Register of Studies Online (CRSO), MEDLINE, Embase, PsycINFO, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Knowledge, the Open System for Information on Grey Literature in Europe (OpenSIGLE), the Latin American and Caribbean Health Science Information Database (LILACS), clinical trial registries, and the reference lists of relevant articles. We conducted the search in October 2017 and applied no language restrictions. </p> </section> <section id="CD010001-sec-0004"> <h3 class="title" id="CD010001-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing vasodilators alone or in combination with other treatments versus placebo or no treatment or versus other agents in women undergoing fertility treatment. </p> </section> <section id="CD010001-sec-0005"> <h3 class="title" id="CD010001-sec-0005">Data collection and analysis</h3> <p>Four review authors independently selected studies, assessed risk of bias, extracted data, and calculated risk ratios (RRs). We combined study data using a fixed‐effect model and assessed evidence quality using Grades of Recommendation, Assessment, Development and Evaluation Working Group (GRADE) methods. Our primary outcomes were live birth or ongoing pregnancy and vasodilator side effects. Secondary outcomes included clinical pregnancy, endometrial thickness, multiple pregnancy, miscarriage, and ectopic pregnancy. </p> </section> <section id="CD010001-sec-0006"> <h3 class="title" id="CD010001-sec-0006">Main results</h3> <p>We included 15 studies with a total of 1326 women. All included studies compared a vasodilator versus placebo or no treatment. We judged most of these studies as having unclear risk of bias. Overall, the quality of evidence was low to moderate for most outcomes. The main limitations were imprecision due to low numbers of events and participants and risk of bias due to unclear methods of randomisation. </p> <p>Vasodilators probably make little or no difference in rates of live birth compared with placebo or no treatment (RR 1.18, 95% confidence interval (CI) 0.83 to 1.69; three RCTs; N = 350; I² = 0%; moderate‐quality evidence) but probably increase overall rates of side effects including headache and tachycardia (RR 2.35, 95% CI 1.51 to 3.66; four RCTs; N = 418; I² = 0%; moderate‐quality evidence). Evidence suggests that if 236 per 1000 women achieve live birth with placebo or no treatment, then between 196 and 398 per 1000 will do so with the use of vasodilators. </p> <p>Compared with placebo or no treatment, vasodilators may slightly improve clinical pregnancy rates (RR 1.45, 95% CI 1.19 to 1.77; 11 RCTs; N = 1054; I² = 6%; low‐quality evidence). Vasodilators probably make little or no difference in rates of multiple gestation (RR 1.15, 95% CI 0.55 to 2.42; three RCTs; N = 370; I² = 0%; low‐quality evidence), miscarriage (RR 0.83, 95% CI 0.37 to 1.86; three RCTs; N = 350; I² = 0%; low‐quality evidence), or ectopic pregnancy (RR 1.48, 95% CI 0.25 to 8.69; two RCTs; N = 250; I² = 5%; low‐quality evidence). All studies found benefit for endometrial thickening, but reported effects varied (I² = 92%) and ranged from a mean difference of 0.80 higher (95% CI 0.18 to 1.42) to 3.57 higher (95% CI 3.01 to 4.13) with very low‐quality evidence, so we are uncertain how to interpret these results. </p> </section> <section id="CD010001-sec-0007"> <h3 class="title" id="CD010001-sec-0007">Authors' conclusions</h3> <p>Evidence was insufficient to show whether vasodilators increase the live birth rate in women undergoing fertility treatment. However, low‐quality evidence suggests that vasodilators may slightly increase clinical pregnancy rates. Moderate‐quality evidence shows that vasodilators increase overall side effects in comparison with placebo or no treatment. Adequately powered studies are needed so that each treatment can be evaluated more accurately. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010001-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010001-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010001-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010001-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010001-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010001-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010001-abs-0009">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010001-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010001-abs-0005" lang="en"> <h3>Vasodilators for women undergoing fertility treatment</h3> <p><b>Review question</b> </p> <p>Researchers at Cochrane reviewed available evidence on the effects of vasodilators (drugs used to widen blood vessels) in women undergoing fertility treatment. </p> <p><b>Background</b> </p> <p>For women undergoing fertility treatment for different causes, interventions aimed at improving the receptivity of the uterus are of utmost importance. Many different drugs have been evaluated, with the aim of increasing rates of implantation and live birth. These include vasodilating agents, which are used to dilate blood vessels to improve endometrial receptivity, thicken the endometrium, and favour uterine relaxation, among other effects. </p> <p><b>Study characteristics</b> </p> <p>We found 15 randomised controlled trials (a type of experiment in which people are randomly allocated to one or more treatment groups) that compared the use of vasodilators versus placebo or no treatment in a total of 1326 women undergoing fertility treatment. The evidence is current to October 2017. </p> <p><b>Key results</b> </p> <p>Only three of the included studies reported live birth rates. Overall, vasodilators probably make little or no difference in rates of live birth. Moderate‐quality evidence shows that vasodilators probably increase overall rates of side effects (including headache and tachycardia (faster than normal heartbeat)) in comparison with placebo or no treatment. However, low‐quality evidence suggests that vasodilators may increase the chance of becoming pregnant. </p> <p><b>Quality of the evidence</b> </p> <p>The evidence is of low to moderate quality. More research is needed (one study is ongoing and will be incorporated into this review in a subsequent update). </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010001-sec-0099" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010001-sec-0099">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010001-sec-0160">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010001-sec-0099"></div> <h3 class="title" id="CD010001-sec-0100">Implications for practice</h3> <section id="CD010001-sec-0100"> <p>Evidence was insufficient to show whether vasodilators increase the live birth rate in women undergoing fertility treatment. However, low‐quality evidence suggests that vasodilators may slightly increase clinical pregnancy rates. Moderate‐quality evidence shows that vasodilators increase some side effects, such as headache and tachycardia, in comparison with placebo or no treatment. Adequately powered studies are needed, so that researchers can evaluate each treatment more accurately. </p> </section> <h3 class="title" id="CD010001-sec-0101">Implications for research</h3> <section id="CD010001-sec-0101"> <p>Although this review suggests that vasodilators increase clinical pregnancy rates compared with placebo or no treatment, future studies on vasodilators should report live birth rates, side effects, and other important outcomes to enable consumers and healthcare providers to make well‐informed decisions on the best treatment options. Based on the results of this review, we provide the following recommendations. </p> <p> <ol id="CD010001-list-0022"> <li> <p>Randomised controlled trials with larger sample sizes are needed to evaluate whether any vasodilator is associated with an increase in live birth rate or pregnancy rate. </p> </li> <li> <p>Future research should help to determine the optimal route of administration and dosage of different vasodilators. </p> </li> <li> <p>Future research probably should focus mainly on tadalafil or amlodipine or "isosorbide mononitrate" and should include assessment of the optimal route of administration and the optimal dosage. </p> </li> <li> <p>Future research should evaluate relevant outcomes such as live births and side effects.</p> </li> <li> <p>Future research should investigate whether women with a thin endometrium may benefit from medication. </p> </li> <li> <p>Improved descriptions of methods and adherence to CONSORT (Consolidated Standards of Reporting Trials) recommendations are needed for all randomised controlled trials. </p> </li> <li> <p>Future researchers should perform comparisons of one active treatment versus another.</p> </li> </ol> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010001-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010001-sec-0029"></div> <div class="table" id="CD010001-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vasodilator compared to placebo or no treatment for women undergoing fertility treatment</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Vasodilator compared to placebo or no treatment for women undergoing fertility treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing fertility treatment<br/> <b>Setting:</b> secondary care<br/> <b>Intervention:</b> vasodilator<br/> <b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vasodilator</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Live birth</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>278 per 1000<br/> (196 to 398) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.18<br/> (0.83 to 1.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>350<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vasodilator side effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>109 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>256 per 1000</p> <p>(164 to 398)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 2.35</p> <p>(1.51 to 3.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>418</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> MODERATE<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>224 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>325 per 1000<br/> (267 to 397) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.45</p> <p>(1.19 to1.77)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1054<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Thickened endometrium</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean thickness of the endometrium was 7.6 mm.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.11 mm higher<br/> (1.16 higher to 3.07 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>477<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,e</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Multiple gestation or birth</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 per 1000<br/> (36 to 158) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.15<br/> (0.55 to 2.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>370<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> LOW<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Spontaneous miscarriage</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000<br/> (26 to 128) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.83<br/> (0.37 to 1.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>350<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> LOW<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ectopic pregnancy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/> (4 to 140) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.48<br/> (0.25 to 8.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> LOW<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; RR: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded for Imprecision (‐1) as confidence interval is wide and the confidence interval includes the line of no effect. </p> <p><sup>b</sup>Downgraded for risk of bias (‐1) owing to unclear random generation sequencing and blinding of participants, personnel, and outcome assessor. </p> <p><sup>c</sup>Downgraded for risk of bias (‐1) owing to some studies having unclear risk and one trial having high risk of bias because of attrition. </p> <p><sup>d</sup>Downgraded for publication bias (‐1). The plot was asymmetrical owing to lack of small non‐significant published studies. </p> <p><sup>e</sup>Downgraded for Inconsistency (‐2) owing to high statistical heterogeneity (92%). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010001-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010001-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010001-sec-0123">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD010001-sec-0030"></div> <section id="CD010001-sec-0031"> <h3 class="title" id="CD010001-sec-0031">Description of the condition</h3> <p>Between 0.2% and 4.7% of babies born in developed countries are conceived through techniques of assisted reproductive technology (ART) (<a href="./references#CD010001-bbs2-0034" title="BouillonC , FauqueP . [Follow‐up of children conceived by assisted reproductive technologies] [Devenir des enfants issus des techniques d'assistance medicale a la procreation.]. Archives of Pediatrics (Organe Officiel de la Societe Francaise de Pediatrie)2013;20(5):575‐9. [PUBMED: 23545282] ">Bouillon 2013</a>; <a href="./references#CD010001-bbs2-0084" title="SunderamS , KissinDM , FlowersL , AndersonJE , FolgerSG , JamiesonDJ , et al. Assisted reproductive technology surveillance ‐ United States, 2009. Morbidity and Mortality Weekly Report Surveillance Summaries/CDC2012;61(7):1‐23. [PUBMED: 23114281] ">Sunderam 2012</a>; <a href="./references#CD010001-bbs2-0085" title="SunderamS , KissinDM , CrawfordSB , FolgerSG , JamiesonDJ , WarnerL , et al. Assisted reproductive technology surveillance ‐ United States, 2014. Morbidity and Mortality Weekly Report Surveillance Summaries2017;66(6):1‐24. ">Sunderam 2017</a>). A total of 1,144,858 babies were reported to have been born worldwide in 2008, 2009, and 2010 (<a href="./references#CD010001-bbs2-0045" title="DyerS , ChambersGM , deMouzonJ , NygrenKG , Zegers‐HochschildF , MansourR , et al. International Committee for Monitoring Assisted Reproductive Technologies World Report: Assisted Reproductive Technology 2008, 2009 and 2010. Human Reproduction2016;31(7):1588‐609. ">Dyer 2016</a>). Worldwide, ART practices are characterised by outcome differences between regions. By 2012‐2013, fresh cycle live birth rates were highest in the United States (29%) and lowest in Japan (5%) (<a href="./references#CD010001-bbs2-0062" title="KushnirVA , BaradDH , AlbertiniDF , DarmonSK , GleicherN . Systematic review of worldwide trends in assisted reproductive technology 2004‐2013. Reproductive Biology and Endocrinology2017;15(1):6. ">Kushnir 2017</a>). In the 17 European countries that report the number of ART procedures, practitioners performed 374,177 ART cycles in a population of 310 million (1175 cycles per million). In these countries, the clinical pregnancy rates for in vitro fertilisation (IVF) per aspiration and per transfer were 29.6% and 34.5%, respectively. Those for intracytoplasmic sperm injection (ICSI) were 27.8% and 32.9% (<a href="./references#CD010001-bbs2-0048" title="European IVF‐Monitoring Consortium (EIM), European Society of Human Reproduction and Embryology (ESHRE), Calhaz‐JorgeC , DeGeyterC , KupkaMS , deMouzonJ , et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Human Reproduction2017;32(10):1957‐73. ">European IVF‐Monitoring Consortium (EIM) 2017</a>). Statistics have been very similar in recent years (<a href="./references#CD010001-bbs2-0043" title="deMouzonJ , GoossensV , BhattacharyaS , CastillaJA , FerrarettiAP , KorsakV , et al. Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE. Human Reproduction2012;27(4):954‐66. [PUBMED: 22343707] ">de Mouzon 2012</a>; <a href="./references#CD010001-bbs2-0047" title="European IVF‐Monitoring Consortium (EIM), European Society of Human Reproduction and Embryology (ESHRE), KupkaMS , D'HoogheT , FerrarettiAP , deMouzonJ , ErbK , CastillaJA , et al. Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHRE. Human Reproduction2016;31(2):233‐48. ">ESHIRE 2016</a>; <a href="./references#CD010001-bbs2-0052" title="FerrarettiAP , GoossensV , deMouzonJ , BhattacharyaS , CastillaJA , KorsakV , et al. Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Human Reproduction2012;27(9):2571‐84. [PUBMED: 22786779] ">Ferraretti 2012</a>; <a href="./references#CD010001-bbs2-0053" title="FerrarettiAP , GoossensV , KupkaM , BhattacharyaS , deMouzonJ , CastillaJA , et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Human Reproduction2013;28(9):2318‐31. [PUBMED: 23842560] ">Ferraretti 2013</a>; <a href="./references#CD010001-bbs2-0083" title="SullivanEA , Zegers‐HochschildF , MansourR , IshiharaO , deMouzonJ , NygrenKG , et al. International Committee for Monitoring Assisted Reproductive Technologies (ICMART) world report: assisted reproductive technology 2004. Human Reproduction2013;28(5):1375‐90. [PUBMED: 23442757] ">Sullivan 2013</a>). </p> <p>According to the World Health Organization, medically assisted reproduction is defined as reproduction brought about through ovulation induction, controlled ovarian stimulation, ovulation triggering, insemination, and ART techniques (<a href="./references#CD010001-bbs2-0092" title="Zegers‐HochschildF , AdamsonGD , deMouzonJ , IshiharaO , MansourR , NygrenK , et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertility and Sterility2009; Vol. 92, issue 5:1520‐4. [PUBMED: 19828144] ">Zegers‐Hochschild 2009</a>; <a href="./references#CD010001-bbs2-0093" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. ">Zegers‐Hochschild 2017</a>). ART refers to "all treatments or procedures that include the in vitro handling of both human oocytes and sperm or of embryos for the purpose of establishing a pregnancy. This includes, but is not limited to, in vitro fertilization and embryo transfer, gamete intrafallopian transfer, zygote intrafallopian transfer, tubal embryo transfer, gamete and embryo cryopreservation, oocyte and embryo donation, and gestational surrogacy" (<a href="./references#CD010001-bbs2-0092" title="Zegers‐HochschildF , AdamsonGD , deMouzonJ , IshiharaO , MansourR , NygrenK , et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertility and Sterility2009; Vol. 92, issue 5:1520‐4. [PUBMED: 19828144] ">Zegers‐Hochschild 2009</a>; <a href="./references#CD010001-bbs2-0093" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. ">Zegers‐Hochschild 2017</a>). The success of assisted reproduction varies depending on several factors, such as maternal age (<a href="./references#CD010001-bbs2-0069" title="MarinakisG , NikolaouD . What is the role of assisted reproduction technology in the management of age‐related infertility?. Human Fertility2011;14(1):8‐15. [PUBMED: 21329469] ">Marinakis 2011</a>; <a href="./references#CD010001-bbs2-0080" title="SchmidtL , SobotkaT , BentzenJG , Nyboe AndersenA . Demographic and medical consequences of the postponement of parenthood. Human Reproduction Update2012;18(1):29‐43. [PUBMED: 21989171] ">Schmidt 2012</a>; <a href="./references#CD010001-bbs2-0091" title="YavasY . Curvilinear relationship between age and assisted reproduction technique success: retrospective analyses of US National ART Surveillance System data from 2010‐2014. Reproductive BioMedicine Online2017;35(6):657‐68. ">Yavas 2017</a>), maternal weight (<a href="./references#CD010001-bbs2-0036" title="CaiJ , LiuL , ZhangJ , QiuH , JiangX , LiP , et al. Low body mass index compromises live birth rate in fresh transfer in vitro fertilization cycles: a retrospective study in a Chinese population. Fertility and Sterility2017;107(2):422‐9.e2. ">Cai 2017</a>; <a href="./references#CD010001-bbs2-0061" title="KawwassJF , KulkarniAD , HippHS , CrawfordS , KissinDM , JamiesonDJ . Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States. Fertility and Sterility.2016;106(7):1742‐50. ">Kawwass 2016</a>; <a href="./references#CD010001-bbs2-0076" title="PinborgA , GaarslevC , HougaardCO , Nyboe AndersenA , AndersenPK , BoivinJ , et al. Influence of female bodyweight on IVF outcome: a longitudinal multicentre cohort study of 487 infertile couples. Reproductive BioMedicine Online2011;23(4):490‐9. [PUBMED: 21856228] ">Pinborg 2011</a>), the number of embryos transferred (<a href="./references#CD010001-bbs2-0070" title="MartinAS , ChangJ , ZhangY , KawwassJF , BouletSL , McKaneP , et al. Perinatal outcomes among singletons after assisted reproductive technology with single‐embryo or double‐embryo transfer versus no assisted reproductive technology. Fertility and Sterility2017;107(4):954‐60. ">Martin 2017</a>; <a href="./references#CD010001-bbs2-0071" title="McLernonDJ , HarrildK , BerghC , DaviesMJ , deNeubourgD , DumoulinJC , et al. Clinical effectiveness of elective single versus double embryo transfer: meta‐analysis of individual patient data from randomised trials. BMJ2010;341:c6945. [PUBMED: 21177530] ">McLernon 2010</a>), the use of gonadotrophins (<a href="./references#CD010001-bbs2-0068" title="MaheshwariA , GibreelA , SiristatidisCS , BhattacharyaS . Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database of Systematic Reviews (online)2011;8:CD006919. [PUBMED: 21833958] ">Maheshwari 2011</a>; <a href="./references#CD010001-bbs2-0072" title="MochtarMH , DanhofNA , AyelekeRO , Van derVeenF , vanWelyM . Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Cochrane Database of Systematic Reviews2017;5:CD005070:doi: 10.1002/14651858.CD005070.pub3. ">Mochtar 2017</a>; <a href="./references#CD010001-bbs2-0077" title="PouwerAW , FarquharC , KremerJA . Long‐acting FSH versus daily FSH for women undergoing assisted reproduction. Cochrane Database of Systematic Reviews2015;(7):CD009577:doi: 10.1002/14651858.CD009577.pub3. ">Pouwer 2015</a>), inadequate endometrial thickness (<a href="./references#CD010001-bbs2-0032" title="BaradwanS , ShafiD , BaradwanA , BashirMS , Al‐JaroudiD . The effect of endometrial thickness on pregnancy outcome in patients with Asherman's syndrome post‐hysteroscopic adhesiolysis. International Journal of Women's Health2018;10:77‐82. ">Baradwan 2018</a>; <a href="./references#CD010001-bbs2-0074" title="OronG , HierschL , RonaS , Prag‐RosenbergR , SapirO , Tuttnauer‐HamburgerM , et al. Endometrial thickness of less than 7.5 mm is associated with obstetric complications in fresh IVF cycles: a retrospective cohort study. reproductive biomedicine online journal2018;6483:30314‐6. ">Oron 2018</a>), uterine contractions (<a href="./references#CD010001-bbs2-0042" title="ChungCH , WongAW , ChanCP , SaravelosSH , KongGW , CheungLP , et al. The changing pattern of uterine contractions before and after fresh embryo transfer and its relation to clinical outcome. Reproductive BioMedicine Online2017;34(3):240‐7. ">Chung 2017</a>; <a href="./references#CD010001-bbs2-0041" title="ChungCH , WongAW , ChanCP , SaravelosSH , KongGW , CheungLP , et al. The changing pattern of uterine contractions before and after fresh embryo transfer and its relation to clinical outcome. Reprod Biomed Online2017;34(3):240‐247. ">Chung 2016</a>), and others. </p> <p>A thin endometrium (measured at &lt; 8 mm by ultrasound scan) has a negative impact on the success of assisted reproduction (<a href="./references#CD010001-bbs2-0038" title="CheckJH . The importance of sonographic endometrial parameters in influencing success following embryo transfer in the modern era and therapeutic options ‐ part 1: the importance of late proliferative phase endometrial thickness. Clinical and Experimental Obstetrics and Gynecology2011; Vol. 38, issue 3:197‐200. [PUBMED: 21995142] ">Check 2011</a>; <a href="./references#CD010001-bbs2-0046" title="EftekharM , TabibnejadN , Alsadat TabatabaieA . The thin endometrium in assisted reproductive technology: an ongoing challenge. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.12.006:1‐7. ">Eftekhar 2017</a>); live births are possible despite thin endometria, but the pregnancy rate among these women is poor (<a href="./references#CD010001-bbs2-0044" title="DixE , CheckJH . Successful pregnancies following embryo transfer despite very thin late proliferative endometrium. Clinical and Experimental Obstetrics and Gynecology2010;37(1):15‐6. [PUBMED: 20420271] ">Dix 2010</a>; <a href="./references#CD010001-bbs2-0060" title="KasiusA , SmitJG , TorranceHL , EijkemansMJ , MolBW , OpmeerBC , et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta‐analysis. Human Reproduction2014;20(4):530‐41. ">Kasius 2014</a>). Investigators have expressed a marked interest in studying the role that the endometrium plays in the success of assisted reproduction (<a href="./references#CD010001-bbs2-0037" title="CasperRF . It's time to pay attention to the endometrium. Fertility and Sterility2011;96(3):519‐21. [PUBMED: 21880272] ">Casper 2011</a>; <a href="./references#CD010001-bbs2-0081" title="SenturkLM , ErelCT . Thin endometrium in assisted reproductive technology. Current Opinion in Obstetrics &amp; Gynecology2008;20(3):221‐8. [PUBMED: 18460935] ">Senturk 2008</a>; <a href="./references#CD010001-bbs2-0088" title="WeissNS , vanVlietMN , LimpensJ , HompesPGA , LambalkCB , MochtarMH , et al. Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta‐analysis. Human Reproduction2017;32(5):1009‐18. ">Weiss 2017</a>). </p> <p>Uterine contractions influence embryo implantation, possibly through mechanical displacement of the embryo. Decreases in pregnancy rates and implantation rates were noted as the frequency of uterine contractions increased. Approaches aimed at inhibiting uterine contractions could improve pregnancy rates for assisted reproduction (<a href="./references#CD010001-bbs2-0031" title="AguilarHN , MitchellBF . Physiological pathways and molecular mechanisms regulating uterine contractility. Human Reproduction2010;16(6):725‐44. [PUBMED: 20551073] ">Aguilar 2010</a>; <a href="./references#CD010001-bbs2-0035" title="BullettiC , deZieglerD . Uterine contractility and embryo implantation. Current Opinion in Obstetrics &amp; Gynecology2006;18(4):473‐84. [PUBMED: 16794431] ">Bulletti 2006</a>; <a href="./references#CD010001-bbs2-0042" title="ChungCH , WongAW , ChanCP , SaravelosSH , KongGW , CheungLP , et al. The changing pattern of uterine contractions before and after fresh embryo transfer and its relation to clinical outcome. Reproductive BioMedicine Online2017;34(3):240‐7. ">Chung 2017</a>; <a href="./references#CD010001-bbs2-0050" title="FanchinR . Assessing uterine receptivity in 2001: ultrasonographic glances at the new millennium. Annals of the New York Academy of Sciences2001;943:185‐202. [PUBMED: 11594540] ">Fanchin 2001</a>; <a href="./references#CD010001-bbs2-0051" title="FanchinR , AyoubiJM . Uterine dynamics: impact on the human reproduction process. Reproductive BioMedicine Online2009;18(Suppl 2):57‐62. [PUBMED: 19406033] ">Fanchin 2009</a>; <a href="./references#CD010001-bbs2-0064" title="LesnyP , KillickSR , TetlowRL , RobinsonJ , MaguinessSD . Uterine junctional zone contractions during assisted reproduction cycles. Human Reproduction Update1998;4(4):440‐5. [PUBMED: 9825859] ">Lesny 1998</a>; <a href="./references#CD010001-bbs2-0073" title="NgEH , LiRH , ChenL , LanVT , TuongHM , QuanS . A randomized double blind comparison of atosiban in patients undergoing IVF treatment. Human Reproduction2014;29(12):2687‐94. ">Ng 2014</a>). </p> </section> <section id="CD010001-sec-0032"> <h3 class="title" id="CD010001-sec-0032">Description of the intervention</h3> <p>Different vasodilating agents have been proposed to thicken the endometrium and to favour uterine relaxation. Agents used in assisted reproduction include sildenafil, glyceryl trinitrate (GTN), nifedipine, amlodipine, pentoxifylline, and isosorbide monohydrate (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). Sildenafil (Viagra) is a phosphodiesterase‐5‐specific inhibitor that increases the vasodilatory effects of nitric oxide on vascular smooth muscle by preventing the degradation of cyclic guanosine monophosphate (cGMP). Studies report that vaginally administered sildenafil could lead to improvement in uterine blood ﬂow (<a href="./references#CD010001-bbs2-0054" title="FetihAN , HabibDM , AbdelaalII , HusseinM , FetihGN , OthmanER . Adding sildenafil vaginal gel to clomiphene citrate in infertile women with prior clomiphene citrate failure due to thin endometrium: a prospective self‐controlled clinical trial. Facts, Views &amp; Vision in ObGyn2017;9(1):21‐27. ">Fetih 2017</a>; <a href="./references#CD010001-bbs2-0082" title="SherG , FischJD . Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertility and Sterility2002;78(5):1073‐6. [PUBMED: 12413996] ">Sher 2002</a>; <a href="./references#CD010001-bbs2-0086" title="TakasakiA , TamuraH , MiwaI , TaketaniT , ShimamuraK , SuginoN . Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertility and Sterility2010;93(6):1851‐8. [PUBMED: 19200982] ">Takasaki 2010</a>;). Nitric oxide donors such as isosorbide monohydrate and GTN are used in assisted reproduction. Glyceryl trinitrate is also used medically as a vasodilator; in 2002 it was discovered that these effects occur because GTN is converted inside the body to nitric oxide by mitochondrial aldehyde dehydrogenase. Glyceryl trinitrate, which is available in the form of tablets, sprays, and patches, is used in assisted reproduction in an effort to improve pregnancy rates (<a href="./references#CD010001-bbs2-0039" title="ChenZ , FosterMW , ZhangJ , MaoL , RockmanHA , KawamotoT , et al. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proceedings of the National Academy of Sciences of the United States of America2005;102(34):12159‐64. [PUBMED: 16103363] ">Chen 2005</a>). <a href="./references#CD010001-bbs2-0030" title="AcharyaS , YasminE , BalenAH . The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies ‐ a report of 20 cases. Human Fertility2009;12(4):198‐203. [PUBMED: 19938908] ">Acharya 2009</a> and <a href="./references#CD010001-bbs2-0065" title="Letur‐KonirschH , DelanianS . Successful pregnancies after combined pentoxifylline‐tocopherol treatment in women with premature ovarian failure who are resistant to hormone replacement therapy. Fertility and Sterility2003;9:439‐41. ">Letur‐Konirsch 2003</a> used pentoxifylline plus vitamin E in women undergoing assisted reproduction. Reports have described successful conception and pregnancy with nifedipine given at doses of 30 mg/d after secondary infertility (<a href="./references#CD010001-bbs2-0090" title="WilsonAG , KirbyJD . Successful pregnancy in a woman with systemic sclerosis while taking nifedipine. Annals of the Rheumatic Diseases1990;49(1):51‐2. [PUBMED: 2310228] ">Wilson 1990</a>). </p> </section> <section id="CD010001-sec-0033"> <h3 class="title" id="CD010001-sec-0033">How the intervention might work</h3> <p>Endometrial thickness varies with vascularity of the endometrium and the sub‐endometrium, regardless of the concentration of oestradiol or progesterone (<a href="./references#CD010001-bbs2-0078" title="Raine‐FenningNJ , CampbellBK , KendallNR , ClewesJS , JohnsonIR . Endometrial and subendometrial perfusion are impaired in women with unexplained subfertility. Human Reproduction2004;19(11):2605‐14. [PUBMED: 15465835] ">Raine‐Fenning 2004</a>). It is well known that some vasodilators, such as vaginal sildenafil citrate, can produce selective endometrial vasodilation: this occurred in two women with Asherman's syndrome (a condition characterised by the presence of adhesions or fibrosis, or both, within the uterine cavity). "These women achieved pregnancy in the first treatment cycle with vaginal sildenafil citrate" (<a href="./references#CD010001-bbs2-0095" title="ZingerM , LiuJH , ThomasMA . Successful use of vaginal sildenafil citrate in two infertility patients with Asherman's syndrome. Journal of Women's Health2006;15(4):442‐4. [PUBMED: 16724891] ">Zinger 2006</a>). Vasodilators also increase radial artery flow, improving the quality of the endometrium in women with a thin endometrium (<a href="./references#CD010001-bbs2-0086" title="TakasakiA , TamuraH , MiwaI , TaketaniT , ShimamuraK , SuginoN . Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertility and Sterility2010;93(6):1851‐8. [PUBMED: 19200982] ">Takasaki 2010</a>). It has been observed in animal studies that sildenafil plays a role in both implantation and decidualisation (cellular changes in the endometrium in preparation for implantation of the embryo caused by the effects of progesterone) by affecting β(3) integrins (which are cell membrane proteins) and vascular endothelial growth factor (VEGF) expression during the implantation period (<a href="./references#CD010001-bbs2-0033" title="BiyiksizPC , FilizS , VuralB . Is sildenafil citrate affect endometrial receptivity? An immunohistochemical study. Gynecological Endocrinology2011;27(10):767‐74. [PUBMED: 21190420] ">Biyiksiz 2011</a>). </p> <p>In addition, we know that markers of endometrial receptivity are reduced during stimulated cycles compared with natural cycles (<a href="./references#CD010001-bbs2-0040" title="ChenQJ , SunXX , LiL , GaoXH , Gemzell‐DanielssonK , ChengLN . Effects of ovarian stimulation on endometrial integrin beta3 and leukemia inhibitory factor expression in the peri‐implantation phase. Fertility and Sterility2008;89(Suppl 5):1357‐63. [PUBMED: 17681328] ">Chen 2008</a>; <a href="./references#CD010001-bbs2-0049" title="EvansJ , HannanNJ , HincksC , RombautsLJ , SalamonsenLA . Defective soil for a fertile seed? Altered endometrial development is detrimental to pregnancy success. Public Library of Science One2012;7(12):e53098. [PUBMED: 23300868] ">Evans 2012</a>; <a href="./references#CD010001-bbs2-0079" title="RevelA . Defective endometrial receptivity. Fertility and Sterility2012;97(5):1028‐32. [PUBMED: 22542142] ">Revel 2012</a>), and that vasodilators have an effect on amelioration of endometrial receptivity when used in combination with an ovarian hyperstimulation protocol (<a href="./references#CD010001-bbs2-0033" title="BiyiksizPC , FilizS , VuralB . Is sildenafil citrate affect endometrial receptivity? An immunohistochemical study. Gynecological Endocrinology2011;27(10):767‐74. [PUBMED: 21190420] ">Biyiksiz 2011</a>). A limited number of studies have reported enhanced endometrial development and increased implantation rates after administration of vasodilators (<a href="./references#CD010001-bbs2-0082" title="SherG , FischJD . Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertility and Sterility2002;78(5):1073‐6. [PUBMED: 12413996] ">Sher 2002</a>; <a href="./references#CD010001-bbs2-0086" title="TakasakiA , TamuraH , MiwaI , TaketaniT , ShimamuraK , SuginoN . Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertility and Sterility2010;93(6):1851‐8. [PUBMED: 19200982] ">Takasaki 2010</a>; <a href="./references#CD010001-bbs2-0095" title="ZingerM , LiuJH , ThomasMA . Successful use of vaginal sildenafil citrate in two infertility patients with Asherman's syndrome. Journal of Women's Health2006;15(4):442‐4. [PUBMED: 16724891] ">Zinger 2006</a>). Glyceryl trinitrate at very low doses showed a significant inhibitory effect on human myometrium in vitro (<a href="./references#CD010001-bbs2-0075" title="OrthTA , ShiSQ , WilliamsonK , ShiL , ChamblissL , CoonrodDV , et al. Additive inhibitory effects of progesterone and sodium nitroprusside on uterine contractility during pregnancy. Reproductive Sciences2011;18(9):868‐75. [PUBMED: 21421898] ">Orth 2011</a>; <a href="./references#CD010001-bbs2-0089" title="WetzkaB , SchaferWR , StehmansA , ZahradnikHP . Effects of nitric oxide donors on the contractility and prostaglandin synthesis of myometrial strips from pregnant and non‐pregnant women. Gynecological Endocrinology2001;15(1):34‐42. [PUBMED: 11293922] ">Wetzka 2001</a>). Pentoxifylline may be beneficial in reducing hydrogen peroxide–induced embryo damage and improving outcomes of in vitro fertilisation (<a href="./references#CD010001-bbs2-0094" title="ZhangX , SharmaRK , AgarwalA , FalconeT . Antioxidant effect of pentoxifylline in reducing oxidative stress induced embryotoxicity. Fertility and Sterility2004;82:324‐5. ">Zhang 2004</a>). It also appears to improve the pregnancy rate among patients with a thin endometrium when combined with vitamin E (<a href="./references#CD010001-bbs2-0030" title="AcharyaS , YasminE , BalenAH . The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies ‐ a report of 20 cases. Human Fertility2009;12(4):198‐203. [PUBMED: 19938908] ">Acharya 2009</a>; <a href="./references#CD010001-bbs2-0067" title="Lédée‐BatailleN , OlivennesF , LefaixJ‐L , ChaouatG , FrydmanR , DelanianS . Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Human Reproduction2002;17:1249‐53. ">Lédée‐Bataille 2002</a>; <a href="./references#CD010001-bbs2-0066" title="Letur‐KönirschH , GuisF , DelanianS . Uterine restoration by radiation sequelae regression with combined pentoxifylline‐tocopherol: a phase II study. Fertility and Sterility2002;77:1219‐26. ">Letur‐Könirsch 2002</a>). Nimodipine, which is a vasodilator calcium channel blocker, may prevent or delay the luteinising hormone (LH) surge during controlled ovarian stimulation cycles when clomiphene citrate is used in sub‐fertile patients undergoing assisted reproduction by intrauterine insemination (<a href="./references#CD010001-bbs2-0028" title="PenziasAS , NguyenKH . Nimodipine to prevent LH surge during ovulation induction: blinded placebo‐controlled RCT (NIMO) [Using nimodipine, a calcium channel blocker, to prevent LH surge in women undergoing controlled ovarian stimulation and intrauterine insemination: a double‐blinded, randomized controlled study]. US National Institutes of Health. ClinicalTrials.gov Identifier: NCT01672801. ">Penzias 2012</a>). </p> </section> <section id="CD010001-sec-0034"> <h3 class="title" id="CD010001-sec-0034">Why it is important to do this review</h3> <p>Several randomised controlled trials (RCTs) have studied the efficacy of different treatments (gonadotrophin‐releasing hormone (GnRH) agonist, progesterone, aspirin, steroids, human chorionic gonadotrophin (hCG), vitamin E, cytokines, and vasodilators) in endometrial preparation for women undergoing assisted reproduction (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0046" title="EftekharM , TabibnejadN , Alsadat TabatabaieA . The thin endometrium in assisted reproductive technology: an ongoing challenge. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.12.006:1‐7. ">Eftekhar 2017</a>; <a href="./references#CD010001-bbs2-0055" title="GelbayaTA , KyrgiouM , LiTC , SternC , NardoLG . Low‐dose aspirin for in vitro fertilization: a systematic review and meta‐analysis. Human Reproduction2007;13(4):357‐64. ">Gelbaya 2005</a>; <a href="./references#CD010001-bbs2-0056" title="GlujovskyD , PesceR , FiszbajnG , SueldoC , HartRJ , CiapponiA . Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database of Systematic Reviews2010;1:CD006359. [PUBMED: 20091592] ">Glujovsky 2010</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0063" title="LensenSF , MandersM , NastriCO , GibreelA , MartinsWP , TemplerGE , et al. Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination. Cochrane Database of Systematic Reviews2016;14(6):CD011424. ">Lensen 2016</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>; <a href="./references#CD010001-bbs2-0087" title="TorresRF , HabanaAE , TansengcoLG . The effect of estrogen supplementation on the endometrium and pregnancy rate among infertile women treated with clomifene citrate: a meta‐analysis. Fertility and Sterility2005;84:S162‐3. ">Torres 2005</a>). However, evidence is insufficient to allow investigators to endorse a particular protocol for endometrial preparation. </p> <p>Researchers have only partially studied the effects of vasodilators on endometrial preparation in fertility treatment. Their role in implantation, decidualisation, and uterine relaxation, among other events, has not been evaluated. A previous systematic review assessed different treatments for endometrial preparation for embryo transfer but excluded the comparison of vasodilators versus other treatments (<a href="./references#CD010001-bbs2-0056" title="GlujovskyD , PesceR , FiszbajnG , SueldoC , HartRJ , CiapponiA . Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database of Systematic Reviews2010;1:CD006359. [PUBMED: 20091592] ">Glujovsky 2010</a>). Instead, the effectiveness of these treatments remains unproven, and this could potentially increase incrementally costs or side effects involved in assisted reproduction. Studies are needed to identify and assess the efficacy and safety of vasodilators used with or without other agents, or compared with placebo or other agents, in women undergoing fertility treatment. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010001-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010001-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010001-sec-0128">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010001-sec-0035"></div> <p>To evaluate the effectiveness and safety of vasodilators in women undergoing fertility treatment. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010001-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010001-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010001-sec-0129">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010001-sec-0036"></div> <section id="CD010001-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010001-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs).</p> <p> <ul id="CD010001-list-0001"> <li> <p>We excluded cross‐over trials, as the design is not valid in this context.</p> </li> </ul> </p> </section> <section id="CD010001-sec-0039"> <h4 class="title">Types of participants</h4> <p>We considered women undergoing fertility treatment, regardless of the thickness of the endometrium. We applied no restrictions on age or comorbidities. </p> <p>For the purposes of this review, fertility treatment means medically assisted reproduction, such as ovulation induction; controlled ovarian stimulation; ovulation triggering; assisted reproductive technology procedures; and intrauterine, intracervical, and intravaginal insemination with the semen of husband, partner, or donor (<a href="./references#CD010001-bbs2-0092" title="Zegers‐HochschildF , AdamsonGD , deMouzonJ , IshiharaO , MansourR , NygrenK , et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertility and Sterility2009; Vol. 92, issue 5:1520‐4. [PUBMED: 19828144] ">Zegers‐Hochschild 2009</a>; <a href="./references#CD010001-bbs2-0093" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. ">Zegers‐Hochschild 2017</a>). </p> </section> <section id="CD010001-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We planned to include vasodilators (nifedipine, nimodipine, pentoxifylline, nitric oxide donors such as GTN and isosorbide mononitrate, and sildenafil, among others) administered via any route, with or without other agents (oestrogen or tocopherol vitamin E) compared with placebo or no treatment or any other active intervention (progesterone, oestrogen, or other). </p> </section> <section id="CD010001-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD010001-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010001-list-0002"> <li> <p>Live birth or ongoing pregnancy</p> </li> <li> <p>Vasodilator side effects: hypotension, headache, tachycardia, or other effects related to vasodilators, as defined by primary study authors </p> </li> </ol> </p> </section> <section id="CD010001-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010001-list-0003"> <li> <p>Clinical pregnancy</p> </li> <li> <p>Thickened endometrium (reported as dichotomous or continuous data)</p> </li> <li> <p>Other adverse events: multiple gestation or birth, spontaneous miscarriage, ectopic pregnancy </p> </li> </ol> </p> <section id="CD010001-sec-0044"> <h6 class="title">Definitions of terms</h6> <p>Terms were defined as follows.</p> <p> <ol id="CD010001-list-0004"> <li> <p><b>Live birth:</b> the complete expulsion or extraction from a woman of a product of fertilisation after 22 completed weeks' gestation, which, after such separation, breathes or shows any other evidence of life, such as heartbeat, umbilical cord pulsation, or definitive movement of voluntary muscles, irrespective of whether the umbilical cord has been cut or the placenta is attached. A birth weight of 500 grams or more can be used if gestational age is unknown. 'Live birth' refers to the individual newborn, for example, a twin delivery represents two live births (<a href="./references#CD010001-bbs2-0093" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. ">Zegers‐Hochschild 2017</a>). </p> <ol id="CD010001-list-0005"> <li> <p><b>Ongoing pregnancy</b> is defined as evidence of a gestational sac with foetal heart motion at 12 weeks, confirmed by ultrasound. </p> </li> </ol> </li> <li> <p><b>Clinical pregnancy:</b> a pregnancy diagnosed by ultrasonographic visualisation of one or more gestational sacs or definitive clinical signs of pregnancy. In addition to intrauterine pregnancy, this includes a clinically documented ectopic pregnancy (<a href="./references#CD010001-bbs2-0093" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. ">Zegers‐Hochschild 2017</a>). </p> </li> <li> <p><b>Thickened endometrium:</b> an endometrium that measures 8 mm or greater, as determined by ultrasound scan. </p> </li> <li> <p><b>Multiple gestation or birth:</b> a pregnancy that involves more than one embryo or fetus (<a href="./references#CD010001-bbs2-0093" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. ">Zegers‐Hochschild 2017</a>). </p> </li> <li> <p><b>Spontaneous abortion or miscarriage:</b> the spontaneous loss of an intrauterine pregnancy before 22 completed weeks' gestation (<a href="./references#CD010001-bbs2-0093" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. ">Zegers‐Hochschild 2017</a>). </p> </li> <li> <p><b>Ectopic pregnancy:</b> a pregnancy outside the uterine cavity diagnosed by ultrasound, surgical visualisation, or histopathology (<a href="./references#CD010001-bbs2-0093" title="Zegers‐HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Fertility and Sterility2017;108(3):393‐406. ">Zegers‐Hochschild 2017</a>). </p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD010001-sec-0045"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all published and unpublished RCTs of vasodilators in fertility treatment, without language restriction and in consultation with the Cochrane Gynaecology and Fertility Group (CGFG) Information Specialist. </p> <section id="CD010001-sec-0046"> <h4 class="title">Electronic searches</h4> <p>For this update, we searched the following databases, trial registers, and websites in October 2017. </p> <p> <ol id="CD010001-list-0006"> <li> <p>Cochrane Gynaecology and Fertility Group (CGFG) Specialised Register of Controlled Trials; PROCITE platform (searched 24 October 2017) (<a href="./appendices#CD010001-sec-0105">Appendix 1</a>). </p> </li> <li> <p>Cochrane Central Register of Controlled Trials, via the Cochrane Register of Studies Online (CRSO Web platform) (searched 24 October 2017) (<a href="./appendices#CD010001-sec-0106">Appendix 2</a>). </p> </li> <li> <p>MEDLINE: Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid (searched from 1946 to 24 October 2017) (<a href="./appendices#CD010001-sec-0107">Appendix 3</a>). </p> </li> <li> <p>Embase: Ovid (searched from 1980 to 24 October 2017) (<a href="./appendices#CD010001-sec-0108">Appendix 4</a>). </p> </li> <li> <p>PsycINFO: Ovid (searched from 1806 to 24 October 2017) (<a href="./appendices#CD010001-sec-0109">Appendix 5</a>). </p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL) EBSCO platform (searched from 1982 to 24 October 2017) (<a href="./appendices#CD010001-sec-0110">Appendix 6</a>). </p> </li> <li> <p>Other electronic sources of trials, including:</p> <ol id="CD010001-list-0007"> <li> <p>clinical trial registries for ongoing and registered trials, including:</p> <ol id="CD010001-list-0008"> <li> <p><a href="http://clinicaltrials.gov/ct2/home" target="_blank">http://www.clinicaltrials.gov (</a>a service of the US National Institutes of Health); and </p> </li> <li> <p><a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">http://www.who.int/trialsearch/Default.aspx</a> (World Health Organization International Trials Registry Platform search portal). </p> </li> </ol> </li> </ol> </li> <li> <p>Latin American Caribbean Health Sciences Literature (LILACS) and other Spanish/Portuguese language databases (searched 24 October 2017), including: </p> <ol id="CD010001-list-0009"> <li> <p>those found in the Virtual Health Library Regional Portal (VHL), at <a href="http://bvsalud.org/portal/?lang=en" target="_blank">http://bvsalud.org/portal/?lang=en</a> . </p> </li> </ol> </li> <li> <p>The Cochrane Library, at <a href="http://www.cochrane.org/index.htm" target="_blank">http://www.cochrane.org/index.htm</a>.  </p> </li> <li> <p>Conference abstracts in the Web of Knowledge, at <a href="http://wokinfo.com/" target="_blank">http://wokinfo.com/</a>. </p> </li> <li> <p>OpenSigle for Grey Literature from Europe, at <a href="http://opensigle.inist.fr/" target="_blank">http://opensigle.inist.fr/</a>. </p> </li> <li> <p>PubMed and Google Scholar (for recent trials not yet indexed in the major databases).</p> </li> </ol> </p> </section> <section id="CD010001-sec-0047"> <h4 class="title">Searching other resources</h4> <p>We reviewed the reference lists of articles retrieved by the aforementioned search. We contacted experts in the field to request additional data. We handsearched conference abstracts of the International Federation of Gynaecology and Obstetrics (FIGO) World Congress from 1985, 1988, 1991, 1994, 1997, 2000, 2003, 2006, 2009, 2012, and 2015, and we checked the references of relevant identified systematic reviews. </p> </section> </section> <section id="CD010001-sec-0048"> <h3 class="title" id="CD010001-sec-0048">Data collection and analysis</h3> <section id="CD010001-sec-0049"> <h4 class="title">Selection of studies</h4> <p>We performed the pertinent statistical analysis in accordance with the guidelines for statistical analysis developed by Cochrane. Review authors (RG or DG and MJM or AV) independently examined titles and abstracts retrieved through the search and determined whether studies met review inclusion criteria. For studies with potential or unclear eligibility, we obtained the full text of the article for independent assessment. If needed, we contacted study investigators to clarify study eligibility. We resolved disagreements by discussion and consensus with a third review author (DG or XB). We documented the selection process in a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) flow chart (<a href="#CD010001-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD010001-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow of information through different phases of the systematic review." data-id="CD010001-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow of information through different phases of the systematic review.</p> </div> </div> </div> </section> <section id="CD010001-sec-0050"> <h4 class="title">Data extraction and management</h4> <p>Review authors (RG or FR and MJM or AV) independently extracted data from eligible studies using a data extraction form designed and pilot‐tested by the review authors. We resolved disagreements by discussion and consensus with a third review author (DG or XB). Data extracted included study characteristics, methods, and outcome data. When a study had multiple publications, we used the main trial report for reference purposes and derived additional details from secondary papers. We contacted the original study authors if we needed further information. For multi‐arm studies, we excluded data from arms that did not meet review eligibility criteria. </p> </section> <section id="CD010001-sec-0051"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Review authors (RG or FR and MJM or AV) independently assessed the included studies for risk of bias using Cochrane's 'Risk of bias' assessment tool (<a href="./references#CD010001-bbs2-0059" title="HigginsJPT , DeeksJJ . Chapter 7. Selecting studies and collecting data. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0(updated March 2011). http://www.cochrane‐handbook.org. ">Higgins 2011</a>). We assessed allocation (random sequence generation and allocation concealment), blinding of participants and personnel, incomplete outcome data, selective reporting, and other biases. We resolved disagreements by discussion and consensus with a third review author. We fully described all judgements and presented conclusions in the 'Risk of bias' table (<a href="#CD010001-fig-0002">Figure 2</a>; <a href="#CD010001-fig-0003">Figure 3</a>), which we incorporated into our interpretation of review findings by performing sensitivity analyses (see below).<br/> <br/> We assessed whether evidence suggested within‐trial selective reporting, including failure to report obvious outcomes or insufficient reporting of outcomes. We searched published protocols to compare outcomes versus those of the corresponding published studies. When a study failed to report live births but did report interim outcomes such as pregnancy, we undertook an informal assessment to determine whether interim values (e.g. clinical pregnancy) were similar to those reported in studies that also reported live births. </p> <div class="figure" id="CD010001-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010001-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010001-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010001-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p> Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD010001-sec-0052"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data (e.g. live births), we calculated risk ratios (RRs) using the numbers of events in control and intervention groups of each study. We presented 95% confidence intervals (CIs) for all outcomes. When data were not available to calculate RRs, we used the most detailed available numerical data that could be used to complete similar analyses (e.g. test statistics, P value). We compared the magnitude and direction of effect reported by studies against the way in which they are presented in the review, while taking account of legitimate differences. For continuous data, we calculated the mean difference (MD) with 95% CI. </p> </section> <section id="CD010001-sec-0053"> <h4 class="title">Unit of analysis issues</h4> <p>We conducted all analyses per woman randomly assigned. When data did not allow valid analyses (e.g. "per cycle" data), we contacted study authors to request "per woman" data. If available data could not be analysed, we planned to summarise the data briefly in an additional table without meta‐analysis. We counted multiple live births (e.g. twins, triplets) as a single live birth event. </p> </section> <section id="CD010001-sec-0054"> <h4 class="title">Dealing with missing data</h4> <p>We analysed data on an intention‐to‐treat basis. We attempted to obtain missing data from the original researchers. We asked trial authors via email or telephone to provide further details. We planned to impute individual values for missing data for any of the primary outcomes, but no study with data for primary outcomes presented important attrition bias. </p> </section> <section id="CD010001-sec-0055"> <h4 class="title">Assessment of heterogeneity</h4> <p>We determined whether clinical and methodological characteristics of included studies were sufficiently similar for meta‐analysis to provide a clinically meaningful summary. We assessed statistical heterogeneity by using the I² statistical measure. We considered an I² value greater than 50% to show evidence of substantial heterogeneity (<a href="./references#CD010001-bbs2-0058" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [PUBMED: 12958120] ">Higgins 2003</a>). When we detected substantial heterogeneity, we explored possible explanations via corresponding analyses. We took statistical heterogeneity into account when interpreting the results. </p> </section> <section id="CD010001-sec-0056"> <h4 class="title">Assessment of reporting biases</h4> <p>If all eligible studies were not retrieved, the review may be biased. The review authors have tried to minimise the potential impact of publication and other reporting biases by ensuring a comprehensive search for eligible studies and by remaining alert to data duplication. If more studies had been included in an analysis, we would have used a funnel plot to explore the possibility of small‐study effects (i.e. the tendency for estimates of the intervention effect to be more beneficial in smaller studies). </p> </section> <section id="CD010001-sec-0057"> <h4 class="title">Data synthesis</h4> <p>When we judged studies to be sufficiently similar, we combined data using a fixed‐effect model for the following comparisons. </p> <p> <ol id="CD010001-list-0010"> <li> <p>Vasodilator (with or without an additional intervention) versus placebo or no treatment.</p> <ol id="CD010001-list-0011"> <li> <p>Glyceryl trinitrate (GTN).</p> </li> <li> <p>Isosorbide mononitrate (ISMN or IMN).</p> </li> <li> <p>Sildenafil.</p> </li> <li> <p>Amlodipine.</p> </li> <li> <p>Tadalafil.</p> </li> <li> <p>Pentoxifylline (PTX) and vitamin E.</p> </li> <li> <p>Sildenafil and oestradiol.</p> </li> </ol> </li> <li> <p>Vasodilator (with or without an additional intervention) versus active intervention.</p> <ol id="CD010001-list-0012"> <li> <p>Stratified by type of vasodilator.</p> </li> </ol> </li> </ol> </p> </section> <section id="CD010001-sec-0058"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If data had been available, we would have conducted subgroup analyses to examine separate evidence within the following subgroups. </p> <p> <ol id="CD010001-list-0013"> <li> <p>Studies in women with thin endometrium (&lt; 8 mm) undergoing fertility treatment.</p> </li> <li> <p>Studies in women with normal endometrial thickness undergoing fertility treatment.</p> </li> <li> <p>Studies including different routes of administration.</p> </li> <li> <p>Studies with and without co‐interventions.</p> </li> </ol> </p> <p>We also performed a post hoc subgroup analysis to evaluate studies that used only vasodilators versus no co‐intervention (vitamin E, oestrogen). </p> </section> <section id="CD010001-sec-0059"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analyses for the primary outcomes to determine whether conclusions were robust enough to withstand arbitrary decisions regarding eligibility and analysis of included studies. </p> <p>These analyses required consideration of whether the review conclusions would have differed if we had adopted a random‐effects model. </p> <section id="CD010001-sec-0060"> <h5 class="title">Overall quality of the body of evidence ‐ 'Summary of findings' table</h5> <p>We prepared a 'Summary of findings' table using GRADEpro and Cochrane methods (<a href="./references#CD010001-bbs2-0057" title="GRADEproGDT . GRADE software for Summary of Findings tables, Health Technology Assessment and Guidelines. https://gradepro.org/. ">GRADEpro GDT 2014</a>; <a href="./references#CD010001-bbs2-0059" title="HigginsJPT , DeeksJJ . Chapter 7. Selecting studies and collecting data. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0(updated March 2011). http://www.cochrane‐handbook.org. ">Higgins 2011</a>). This table presents overall quality of the body of evidence for the review outcomes live birth or ongoing pregnancy, vasodilator side effects, clinical pregnancy, thickened endometrium, multiple gestation, spontaneous miscarriage, and ectopic pregnancy for the main review comparison (vasodilator vs placebo or no treatment). We assessed the quality of evidence using GRADE criteria: risk of bias, consistency of effect, imprecision, indirectness, and publication bias. Two review authors (MJM and AV) working independently judged evidence quality (high, moderate, low, or very low) and resolved disagreements by discussion. We justified, documented, and incorporated judgements into reporting of results for each outcome. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010001-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010001-sec-0061"></div> <section id="CD010001-sec-0062"> <h3 class="title">Description of studies</h3> <section id="CD010001-sec-0063"> <h4 class="title">Results of the search</h4> <p>Through the search, we retrieved 779 articles. A total of 29 studies were potentially eligible, and we retrieved those full texts. Fifteen studies met the inclusion criteria of this review (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). We excluded 11 studies (<a href="./references#CD010001-bbs2-0016" title="AlborziS , GhotbiS , ParsanezhadME , DehbashiS , AlborziS , AlborziM . Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double‐blind, randomized, placebo‐controlled study. Journal of Minimally Invasive Gynecology2007; Vol. 14, issue 1:54‐8. ">Alborzi 2007</a>; <a href="./references#CD010001-bbs2-0017" title="AtaallaWM , ElhamidT , ElhalwagyAE . Adjuvant sildenafil therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double‐blind, placebo‐controlled trial. Middle East Fertility Society Journal2016;21(3):175‐9. ">Ataalla 2016</a>; <a href="./references#CD010001-bbs2-0018" title="BalaschJ , CreusM , FabreguesF , CarmonaF , Martinez‐RomanS , ManauD , et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Human Reproduction1997; Vol. 12, issue 9:2046‐50. ">Balasch 1997</a>; <a href="./references#CD010001-bbs2-0019" title="CheckJH , GrazianoV , LeeG , NazariA , ChoeJK , DietterichC . Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clinical &amp; Experimental Obstetrics &amp; Gynecology2004; Vol. 31, issue 2:99‐102. ">Check 2004</a>; <a href="./references#CD010001-bbs2-0020" title="CreusM , FabreguesF , CarmonaF , delPinoM , ManauD , BalaschJ . Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis‐associated infertility: a preliminary trial. Human Reproduction2008; Vol. 23, issue 8:1910‐6. ">Creus 2008</a>; <a href="./references#CD010001-bbs2-0021" title="KamencicH , ThielJA . Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. Journal of Minimally Invasive Gynecology2008;15(1):62‐6. [PUBMED: 18262146] ">Kamencic 2008</a>; <a href="./references#CD010001-bbs2-0022" title="MalinovaM , AbouytaT , KrastevaM . [The effect of vaginal sildenafil citrate on uterine blood flow and endometrium in the infertile women]. Akusherstvo Ginekologiia2013;52(Suppl 1):26‐30. ">Malinova 2013</a>; <a href="./references#CD010001-bbs2-0023" title="Raine‐FenningNJ , CampbellBK , ClewesJS , KendallNR , JohnsonIR . Viagra increases endometrial and sub‐endometrial blood flow but not endometrial volume or thickness. Human Reproduction2009; Vol. 24(Suppl 1):i201, Abstract No P‐505; Poster. ">Raine‐Fenning 2009</a>; <a href="./references#CD010001-bbs2-0024" title="RosenMA , RoizenMF , Eger EI2d , GlassRH , MartinM , DandekarPV , et al. The effect of nitrous oxide on in vitro fertilization success rate. Anesthesiology1987; Vol. 67, issue 1:42‐4. ">Rosen 1987</a>; <a href="./references#CD010001-bbs2-0025" title="SherG , FischJD . Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Human Reproduction2000;15(4):806‐9. ">Sher 2000</a>; <a href="./references#CD010001-bbs2-0026" title="HwangJ , ChangH , LeeJ , ChoiH , ChoP , ChoP , et al. Use of vaginal sildenafil and estradiol valerate to improve endometrial receptivity for the patients with thin endometrium in IVF‐ET. 17th World Congress of Fertility and Sterility, Melbourme, 25‐30 November. 2001. ShinSY , KimDW , ShinJH , HongSY , ParkW , ChoBG , et al. Effectiveness of estradiol and sildenafil supplement therapy in IVF. ET patients with thin endometrium. Korean Society of Obstetrics and Gynecology2002;45:642‐50. ">Shin 2002</a>); two studies are awaiting classification (<a href="./references#CD010001-bbs2-0027" title="CasperR , BentovY . Use of a calcium channel blocker to prevent premature luteinizing hormone surges in infertility patients (nimodipine). US National Institutes of Health. ClinicalTrials.gov Identifier: NCT01551368. ">Casper 2013</a>; <a href="./references#CD010001-bbs2-0028" title="PenziasAS , NguyenKH . Nimodipine to prevent LH surge during ovulation induction: blinded placebo‐controlled RCT (NIMO) [Using nimodipine, a calcium channel blocker, to prevent LH surge in women undergoing controlled ovarian stimulation and intrauterine insemination: a double‐blinded, randomized controlled study]. US National Institutes of Health. ClinicalTrials.gov Identifier: NCT01672801. ">Penzias 2012</a>); and one study is ongoing (<a href="./references#CD010001-bbs2-0029" title="NCT02072291 . The influence of nifedipine treatment on uterine contractility during frozen embryo transfer. [Nifedipine treatment on uterine contractility in IVF]. https://clinicaltrials.gov/ct2/show/NCT02072291 (first received 26 February 2014). ">NCT02072291</a>). </p> <p>For further information, see the following tables: <a href="./references#CD010001-sec-0119" title="">Characteristics of included studies</a>; <a href="./references#CD010001-sec-0120" title="">Characteristics of excluded studies</a>; <a href="./references#CD010001-sec-0121" title="">Characteristics of studies awaiting classification</a>; and <a href="./references#CD010001-sec-0122" title="">Characteristics of ongoing studies</a>. </p> <p>See <a href="#CD010001-fig-0001">Figure 1</a> (PRISMA study screening and selection flow chart) for details of this process. </p> </section> <section id="CD010001-sec-0064"> <h4 class="title">Included studies</h4> <section id="CD010001-sec-0065"> <h5 class="title">Study design and setting</h5> <p>We included in this review 15 randomised controlled trials (RCTs) with a parallel design (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). Publication dates for the included studies ranged from 1993 to 2017. Most studies were conducted at hospital clinics for infertility. </p> </section> <section id="CD010001-sec-0066"> <h5 class="title">Participants</h5> <p>We included in this review 15 studies with a total of 1326 women.</p> <p>The studies included 690 women in the intervention groups and 636 in the control groups. Mean participant age was 31.50 (± 4.92) years. Four trials included women with a 'poor prognosis' (i.e. infertile women with a thin endometrium or an antecedent of poor endometrial response, or with a history of two or more previous implantation failures) (<a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>). Eleven trials included women with a 'good prognosis' (i.e. women without a previous history of failure of zygote intrafallopian transfer (ZIFT) or in vitro fertilisation (IVF), or women with unexplained infertility, or women with infertility and with regular menstrual cycles, or women who had received a diagnosis of polycystic ovarian syndrome) (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). Eight of the 15 studies were performed in women undergoing ART (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>), one was performed in women undergoing artificial insemination (<a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>), and six involved ovulation induction (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>). </p> </section> <section id="CD010001-sec-0067"> <h5 class="title">Interventions</h5> <p>Vasodilators used in these studies included pentoxifylline 400 mg twice daily + tocopherol vitamin E 400 mg twice daily 2 cycles before starting ZIFT cycle until the β‐hCG became positive or the cycle was cancelled (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>); nitric oxide donors (isosorbide mononitrate (ISMN)) 20 mg vaginally until diagnosis of ovulation and pregnancy (<a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>); isosorbide mononitrate (IMN) 10 mg vaginal tablets from cycle day 5 to 9 (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>); 10 mg isosorbide mononitrate (ISMN) tablets applied vaginally from day 2 to day 15 of the cycle or 20 mg ISMN tablets applied vaginally from day 2 to day 15 of the cycle (<a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>); glyceryl trinitrate (GTN) 0.4 mg oral dose 15 minutes before fresh ET (<a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>); sildenafil citrate tablets (50 mg) daily (from first day of cycle until day progesterone was started) (<a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>); sildenafil 25 mg vaginally 4 times a day from day 5 of cycle until day of hCG administration (<a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>); sildenafil citrate 25 mg orally 3 times/d from seventh to 11th day of cycle (<a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>); amlodipine (<a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>); tadalafil oral 5 mg/d for 7 days (from fourth day until 10th day of the cycle) (<a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>); vaginal sildenafil 25 mg/d + oral oestradiol valerate 4 mg/d from day of embryo transfer until pregnancy test (11 days) (<a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>); 5 mg glyceryl trinitrate (GTN) patch applied once daily, beginning the morning of the day before transfer, just after transvaginal ultrasonography and colour doppler were performed (<a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>); 2 sublingual spray emissions of GTN 400 μg/spray (<a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>); sildenafil citrate in the IVF cycle (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>); and glyceryl trinitrate skin patches 5 mg daily for 2 weeks (<a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>). </p> <p> <ol id="CD010001-list-0014"> <li> <p>Thirteen of 15 studies compared vasodilator alone versus placebo or no treatment (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). </p> </li> <li> <p>Two of 15 studies compared vasodilator plus another agent versus placebo or no treatment (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>). </p> </li> </ol> </p> </section> <section id="CD010001-sec-0068"> <h5 class="title">Outcomes</h5> <p>Researchers reported the following outcomes.</p> <p> <ol id="CD010001-list-0015"> <li> <p>Three of 15 studies reported live births (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>). </p> </li> <li> <p>Four of 15 studies reported side effects (<a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). </p> </li> <li> <p>Eight of 15 studies reported clinical pregnancy (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>). However, four studies reported biochemical pregnancy (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>), and three studies did not report the method used to diagnose pregnancy (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). We did not include in analyses studies reporting biochemical pregnancy. </p> </li> <li> <p>Four of 15 studies reported other adverse events (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>). In one study, reproductive loss in the control group looks unusually high (20%), but the adverse event was not defined (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>). </p> </li> </ol> </p> <p>No study provided data on the number of participants with thickened endometrium. Only two studies mentioned that all women had a thin endometrium before treatment (<a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>). However, five studies reported a mean difference in thickened endometrium (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>). </p> </section> </section> <section id="CD010001-sec-0069"> <h4 class="title">Excluded studies</h4> <p>We excluded 11 studies from the review for the following reasons.</p> <p> <ol id="CD010001-list-0016"> <li> <p>Five of 11 studies were not parallel RCTs (<a href="./references#CD010001-bbs2-0017" title="AtaallaWM , ElhamidT , ElhalwagyAE . Adjuvant sildenafil therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double‐blind, placebo‐controlled trial. Middle East Fertility Society Journal2016;21(3):175‐9. ">Ataalla 2016</a>; <a href="./references#CD010001-bbs2-0019" title="CheckJH , GrazianoV , LeeG , NazariA , ChoeJK , DietterichC . Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clinical &amp; Experimental Obstetrics &amp; Gynecology2004; Vol. 31, issue 2:99‐102. ">Check 2004</a>; <a href="./references#CD010001-bbs2-0023" title="Raine‐FenningNJ , CampbellBK , ClewesJS , KendallNR , JohnsonIR . Viagra increases endometrial and sub‐endometrial blood flow but not endometrial volume or thickness. Human Reproduction2009; Vol. 24(Suppl 1):i201, Abstract No P‐505; Poster. ">Raine‐Fenning 2009</a>; <a href="./references#CD010001-bbs2-0025" title="SherG , FischJD . Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Human Reproduction2000;15(4):806‐9. ">Sher 2000</a>; <a href="./references#CD010001-bbs2-0026" title="HwangJ , ChangH , LeeJ , ChoiH , ChoP , ChoP , et al. Use of vaginal sildenafil and estradiol valerate to improve endometrial receptivity for the patients with thin endometrium in IVF‐ET. 17th World Congress of Fertility and Sterility, Melbourme, 25‐30 November. 2001. ShinSY , KimDW , ShinJH , HongSY , ParkW , ChoBG , et al. Effectiveness of estradiol and sildenafil supplement therapy in IVF. ET patients with thin endometrium. Korean Society of Obstetrics and Gynecology2002;45:642‐50. ">Shin 2002</a>). </p> </li> <li> <p>Four of 11 studies did not include participants of interest for this review (<a href="./references#CD010001-bbs2-0016" title="AlborziS , GhotbiS , ParsanezhadME , DehbashiS , AlborziS , AlborziM . Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double‐blind, randomized, placebo‐controlled study. Journal of Minimally Invasive Gynecology2007; Vol. 14, issue 1:54‐8. ">Alborzi 2007</a>; <a href="./references#CD010001-bbs2-0018" title="BalaschJ , CreusM , FabreguesF , CarmonaF , Martinez‐RomanS , ManauD , et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Human Reproduction1997; Vol. 12, issue 9:2046‐50. ">Balasch 1997</a>; <a href="./references#CD010001-bbs2-0020" title="CreusM , FabreguesF , CarmonaF , delPinoM , ManauD , BalaschJ . Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis‐associated infertility: a preliminary trial. Human Reproduction2008; Vol. 23, issue 8:1910‐6. ">Creus 2008</a>; <a href="./references#CD010001-bbs2-0021" title="KamencicH , ThielJA . Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. Journal of Minimally Invasive Gynecology2008;15(1):62‐6. [PUBMED: 18262146] ">Kamencic 2008</a>). </p> </li> <li> <p>One of 11 studies did not include comparisons of interest for this review (<a href="./references#CD010001-bbs2-0024" title="RosenMA , RoizenMF , Eger EI2d , GlassRH , MartinM , DandekarPV , et al. The effect of nitrous oxide on in vitro fertilization success rate. Anesthesiology1987; Vol. 67, issue 1:42‐4. ">Rosen 1987</a>). </p> </li> <li> <p>One of 11 studies did not include outcomes of interest for this review (<a href="./references#CD010001-bbs2-0022" title="MalinovaM , AbouytaT , KrastevaM . [The effect of vaginal sildenafil citrate on uterine blood flow and endometrium in the infertile women]. Akusherstvo Ginekologiia2013;52(Suppl 1):26‐30. ">Malinova 2013</a>). </p> </li> </ol> </p> <p>In addition, two studies are awaiting classification (<a href="./references#CD010001-bbs2-0027" title="CasperR , BentovY . Use of a calcium channel blocker to prevent premature luteinizing hormone surges in infertility patients (nimodipine). US National Institutes of Health. ClinicalTrials.gov Identifier: NCT01551368. ">Casper 2013</a>; <a href="./references#CD010001-bbs2-0028" title="PenziasAS , NguyenKH . Nimodipine to prevent LH surge during ovulation induction: blinded placebo‐controlled RCT (NIMO) [Using nimodipine, a calcium channel blocker, to prevent LH surge in women undergoing controlled ovarian stimulation and intrauterine insemination: a double‐blinded, randomized controlled study]. US National Institutes of Health. ClinicalTrials.gov Identifier: NCT01672801. ">Penzias 2012</a>), and one study is ongoing (<a href="./references#CD010001-bbs2-0029" title="NCT02072291 . The influence of nifedipine treatment on uterine contractility during frozen embryo transfer. [Nifedipine treatment on uterine contractility in IVF]. https://clinicaltrials.gov/ct2/show/NCT02072291 (first received 26 February 2014). ">NCT02072291</a>). </p> </section> </section> <section id="CD010001-sec-0070"> <h3 class="title">Risk of bias in included studies</h3> <p>In <a href="#CD010001-fig-0002">Figure 2</a> and <a href="#CD010001-fig-0003">Figure 3</a>, we have shown and summarised the judgements of review authors regarding each risk of bias item for each included study. </p> <section id="CD010001-sec-0071"> <h4 class="title">Allocation</h4> <section id="CD010001-sec-0072"> <h5 class="title">Random sequence generation</h5> <p>Five studies had low risk of selection bias related to sequence generation (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>). The other 10 studies did not describe the method of randomisation, and we ranked them as having unclear risk of bias (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). </p> </section> <section id="CD010001-sec-0073"> <h5 class="title">Allocation concealment</h5> <p>Five studies had low risk of bias related to allocation concealment (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>). The other 10 studies did not describe the method used to conceal the sequence, and we ranked them as having unclear risk of bias (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). </p> </section> </section> <section id="CD010001-sec-0074"> <h4 class="title">Blinding</h4> <p>Five of 15 studies had low risk of performance bias (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). Four of these were double‐blind and used placebo as a control (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>), and one was single‐blind (surgeons who conducted the operations were blinded) (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>). Three studies did not provide a description of blinding (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>). </p> <p>Eight of 15 studies had low risk of detection bias (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>). Seven of 15 studies did not mention blinding, and we judged them as having unclear risk of detection bias (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). Blinding was not considered as likely to influence the outcome of live birth or clinical pregnancy. The same was not true for adverse events, for which lack of blinding could potentially affect findings. </p> </section> <section id="CD010001-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>Nine of 15 studies analysed all or most (&gt; 95%) of the women randomly assigned and had low risk of attrition bias (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). Only one study used the number of cycles instead of the number of participants in analysis (<a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>), and four studies did not describe attrition (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>). These studies had unclear risk of attrition bias. One of 15 studies was at high risk of attrition bias (<a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>). </p> </section> <section id="CD010001-sec-0076"> <h4 class="title">Selective reporting</h4> <p>Ten of 15 studies reported outcomes that were clearly prespecified in the methods section, and we classified them as having low risk of selective reporting bias (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). Four of these studies reported primary outcomes (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>): three studies reported live birth (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>), and four reported adverse effects (<a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). However, the protocol was available for only one study (<a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>). </p> </section> <section id="CD010001-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>Twelve of 15 studies reported baseline balance between groups in terms of age and duration of infertility (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). In addition, four studies reported baseline comparability regarding type of infertility, cause of infertility, and body mass index. We classified these studies as having low risk of bias. We identified no other potential sources of bias. However, three studies did not report baseline features, and we judged them to have unclear risk of detection bias (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>). </p> </section> </section> <section id="CD010001-sec-0078"> <h3 class="title" id="CD010001-sec-0078">Effects of interventions</h3> <p>See: <a href="./full#CD010001-tbl-0001"><b>Summary of findings for the main comparison</b> Vasodilator compared to placebo or no treatment for women undergoing fertility treatment</a> </p> <section id="CD010001-sec-0079"> <h4 class="title">1. Vasodilator (with or without an additional intervention) versus placebo or no treatment</h4> <section id="CD010001-sec-0080"> <h5 class="title">Primary outcomes</h5> <section id="CD010001-sec-0081"> <h6 class="title">1.1. Live birth or ongoing pregnancy</h6> <p>(<a href="./references#CD010001-fig-0007" title="">Analysis 1.1</a>; <a href="#CD010001-fig-0004">Figure 4</a>) </p> <div class="figure" id="CD010001-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.1 Live birth." data-id="CD010001-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.1 Live birth. </p> </div> </div> </div> <p>Three studies reported this outcome. All reported live births.</p> <p> <ol id="CD010001-list-0017"> <li> <p>Comparison of glyceryl trinitrate (GTN) versus placebo (<a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>). </p> </li> <li> <p>Comparison of pentoxifylline + tocopherol vitamin E versus no treatment (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>). </p> </li> </ol> </p> <p>Vasodilators (given alone or with another agent) probably make little or no difference in rates of "live birth or ongoing pregnancy" compared with placebo or no treatment (RR 1.18, 95% CI 0.83 to 1.69; three RCTs; N = 350; I² = 0%; moderate‐quality evidence; <a href="./references#CD010001-fig-0007" title="">Analysis 1.1</a>; <a href="#CD010001-fig-0004">Figure 4</a>; <a href="./full#CD010001-tbl-0001">summary of findings Table for the main comparison</a>). Limiting the analysis to studies of vasodilators given without a co‐intervention did not substantially change the main finding (RR 1.09, 95% CI 0.69 to 1.72; two RCTs; N = 238; I² = 0%; moderate‐quality evidence). </p> <p>We stratified the analysis by type of vasodilator. The test for subgroup differences shows no evidence of differences between subgroups for this outcome (Chi² = 0.33, df = 1 (P = 0.56), I² = 0%). </p> <p>Sensitivity analyses based on a random‐effects model did not change the evidence (RR 1.18, 95% CI 0.83 to 1.69; three RCTs; N = 350; I² = 0%; moderate‐quality evidence). </p> </section> <section id="CD010001-sec-0082"> <h6 class="title">1.2. Vasodilator side effects</h6> <p>(<a href="./references#CD010001-fig-0008" title="">Analysis 1.2</a>: <a href="#CD010001-fig-0005">Figure 5</a>) </p> <div class="figure" id="CD010001-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.2 Vasodilator side effects." data-id="CD010001-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.2 Vasodilator side effects. </p> </div> </div> </div> <p>Four studies reported the number of vasodilator side effects by group. Two assessed glyceryl trinitrate (GTN) versus placebo (<a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>), one sildenafil versus placebo (<a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>), and another isosorbide mononitrate (ISMN) versus no treatment (<a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>). </p> <p>The vasodilator group most commonly reported the following adverse events (AEs): hypotension, headache, tachycardia, dizziness, hot flushes, nervousness, insomnia, constipation, and a feeling of weakness. </p> <p>Vasodilators (alone or with another agent) probably increase side effects compared with placebo or no treatment (RR 2.35, 95% CI 1.51 to 3.66; four RCTs; N = 418; I² = 0%; moderate‐quality evidence). </p> <p>We stratified the analysis by type of vasodilator. The test for subgroup differences shows no evidence of differences between subgroups for this outcome (Chi² = 1.12, df = 2 (P = 0.57), I² = 0%). </p> </section> <section id="CD010001-sec-0083"> <h6 class="title">1.3. Specific vasodilator side effects</h6> <p>Two studies reported specific vasodilator side effects. One compared sildenafil versus placebo (<a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>), and another isosorbide mononitrate (ISMN) versus no treatment (<a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>). Vasodilators may increase headache (RR 4.12, 95% CI 1.87 to 9.06; two RCTs; N = 160; I² = 7%; low‐quality evidence) and tachycardia (RR 3.83, 95% CI 1.25 to 11.75; one RCT; N = 90; low‐quality evidence). Evidence was insufficient to show whether groups had differences in hypotension (RR 1.11, 95% CI 0.58 to 2.14; one RCT; N = 90; low‐quality evidence), dizziness (RR 1.57, 95% CI 0.76 to 3.26; one RCT; N = 90; low‐quality evidence), or hot flushes (RR 2.40, 95% CI 0.96 to 5.99; two RCTs; N = 160; I² = 7%; low‐quality evidence). </p> </section> </section> <section id="CD010001-sec-0084"> <h5 class="title">Secondary outcomes</h5> <section id="CD010001-sec-0085"> <h6 class="title">1.4. Clinical pregnancy</h6> <p>(<a href="./references#CD010001-fig-0010" title="">Analysis 1.4</a>; <a href="#CD010001-fig-0006">Figure 6</a>) </p> <div class="figure" id="CD010001-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.4 Clinical pregnancy." data-id="CD010001-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.4 Clinical pregnancy. </p> </div> </div> </div> <p>Fifteen studies reported clinical pregnancy. However, four studies reported biochemical pregnancy, and we did not include them in the analysis (<a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0007" title="El‐BerryS , RazikMA . Nitric oxide donors increase pregnancy rate in clomiphene citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal2010;15:106‐9. ">El‐Berry 2010</a>; <a href="./references#CD010001-bbs2-0008" title="FahmyAA , ElSokkaryM , SayedS . The value of oral sildenafil in the treatment of female infertility: a randomized clinical trial. Life Science Journal2015;12(4):78‐82. ">Fahmy 2015</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>). Two studies did not report the method used to diagnose pregnancy (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). We included them in the analyses and noted this limitation in the footnotes. We analysed 11 studies (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>; <a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>; <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>; <a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>; <a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>; <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a>). </p> <p> <ol id="CD010001-list-0018"> <li> <p><a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005,</a><a href="./references#CD010001-bbs2-0013" title="MostafaR , MotaweB . Nitric oxide donors and uterine artery Doppler blood flow: a step for optimizing uterine receptivity and implantation in ICSI. Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain of the European Society of Human Reproduction and Embryology. 2003; Vol. 1:138. ">Mostafa 2003,</a><a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002,</a> and <a href="./references#CD010001-bbs2-0015" title="ShakerA , FlemingR , JamiesonME , YatesRWS , CouttsJRT . Assessments of embryo transfer after in‐vitro fertilization: effects of glyceryl trinitrate. Human Reproduction1993;8(9):1426‐8. ">Shaker 1993</a> compared glyceryl trinitrate (GTN) versus placebo or no treatment. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a> and <a href="./references#CD010001-bbs2-0006" title="Dehghani FirouzabadiR , DavarR , HojjatF , MahdaviM . Effect of sildenafil citrate on endometrial preparation and outcome of frozen‐thawed embryo transfer cycles: a randomized clinical trial. Iranian Journal of Reproductive Medicine2013;11(2):151‐8. ">Dehghani Firouzabadi 2013</a> compared sildenafil versus no treatment or placebo. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a> compared sildenafil plus oestrogen versus no treatment. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a> compared pentoxifylline (PTX) + tocopherol vitamin E versus no treatment. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a> compared isosorbide mononitrate (IMN or ISMN) versus placebo or no treatment. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a> compared amlodipine versus placebo. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a> compared tadalafil versus placebo. </p> </li> </ol> </p> <p>Vasodilators (alone or with another agent) may slightly improve clinical pregnancy compared with placebo or no treatment (RR 1.45, 95% CI 1.19 to 1.77; 11 RCTs; N = 1054; I² = 6%; low‐quality evidence; <a href="./references#CD010001-fig-0010" title="">Analysis 1.4</a>; <a href="#CD010001-fig-0006">Figure 6</a>; <a href="./full#CD010001-tbl-0001">summary of findings Table for the main comparison</a>). Limiting the analysis to studies of vasodilators without a co‐intervention (vitamin E, oestrogen) did not substantially change the main findings (RR 1.43, 95% CI 1.13 to 2.20; 11 RCTs; N = 1054; I² = 21%; moderate‐quality evidence). </p> <p>We stratified the analysis by type of vasodilator. The test for subgroup differences did not clearly suggest any differences between subgroups for this outcome (Chi² = 9.93, df = 6 (P = 0.13), I² = 39%). </p> </section> <section id="CD010001-sec-0086"> <h6 class="title">1.5. Thickened endometrium</h6> <p>Five studies reported thickened endometrium. Two assessed isosorbide mononitrate (IMN or ISMN) (<a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a>; <a href="./references#CD010001-bbs2-0012" title="MahranA , AbdelmegedA , ShawkiA , MoheyeldenA , MohamedA . Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: an RCT. International Journal of Reproductive Biomedicine2016;14(1):9‐14. ">Mahran 2016</a>), one amlodipine (<a href="./references#CD010001-bbs2-0004" title="AzmyO , ElFahamD , TahaT , BibarsM , SalamaS , AbbassyA . Amlodipine effect on pre‐ovulatory follicle blood flow among women with polycystic ovarian syndrome: randomised controlled trial. British Journal of Obstetrics and Gynaecology2016;123(Suppl 2):227. ">Azmy 2016</a>), one sildenafil (<a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>), and one tadalafil (<a href="./references#CD010001-bbs2-0011" title="Magdi AmmarI , Ahmed SalemM . Effect of oral tadalafil on endometrial thickness in patients receiving clomiphene citrate for ovulation induction. Middle East Fertility Society Journal2017;https://doi.org/10.1016/j.mefs.2017.09.001:1‐5. ">Magdi Ammar 2017</a>); researchers compared these agents versus placebo or no treatment. The effects shown in each study varied (I² = 92%) and ranged from a mean difference of 0.80 higher (95% CI 0.18 to 1.42) to 3.57 higher (95% CI 3.01 to 4.13). We are uncertain whether vasodilators improved thickened endometrium, as we have assessed the quality of the evidence as very low. We downgraded the quality of evidence because of high risk of bias and inconsistency (<a href="./references#CD010001-fig-0011" title="">Analysis 1.5</a>; <a href="./full#CD010001-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD010001-sec-0087"> <h6 class="title">1.6. Other adverse events</h6> <section id="CD010001-sec-0088"> <p><b>1.6.1. Multiple gestation or birth</b></p> <p>Three studies reported this outcome.</p> <p> <ol id="CD010001-list-0019"> <li> <p><a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a> compared glyceryl trinitrate (GTN) versus placebo. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a> compared pentoxifylline + tocopherol vitamin E versus no treatment. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0001" title="Abdel RazikM , El‐BerryS , El‐NezamyA , SaadA , Abdel WahabA . Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study. Gynecological Endocrinology2017;33(3):199‐202. ">Abdel 2017</a> compared isosorbide mononitrate (IMN) versus placebo. </p> </li> </ol> </p> <p>Vasodilators probably make little or no difference in rates of multiple gestation or birth compared with placebo or no treatment (RR 1.15, 95% CI 0.55 to 2.42; three RCTs; N = 370; I² = 0%; moderate‐quality evidence) (<a href="./references#CD010001-fig-0012" title="">Analysis 1.6</a>; <a href="./full#CD010001-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD010001-sec-0089"> <p><b>1.6.2. Spontaneous miscarriage</b></p> <p>Four studies reported this outcome.</p> <p> <ol id="CD010001-list-0020"> <li> <p><a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a> and <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a> compared glyceryl trinitrate (GTN) versus placebo. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a> compared pentoxifylline + tocopherol vitamin E versus no treatment. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a> compared sildenafil versus no treatment. </p> </li> </ol> </p> <p>In one study, the miscarriage rate in the control group looked unusually high (<a href="./references#CD010001-bbs2-0003" title="AlievaK , KulakovaE , IpatovaM , SmolnikovaS , KalininaE . Efficiency of recovery physiotherapy and sildenafil citrate in complex preparation of endometrium in women with disorders in uterine hemodynamics undergoing IVF. Human Reproduction2012;27(Suppl 2):P‐276. ">Alieva 2012</a>). So, we analysed only three studies (<a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a>; <a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a>). Vasodilators probably make little or no difference in spontaneous abortion/miscarriage rates compared with placebo or no treatment (RR 0.83, 95% CI 0.37 to 1.86; three RCTs; N = 350; I² = 0%; moderate‐quality evidence). </p> </section> <section id="CD010001-sec-0090"> <p><b>1.6.3. Ectopic pregnancy</b></p> <p>Two studies reported this outcome.</p> <p> <ol id="CD010001-list-0021"> <li> <p><a href="./references#CD010001-bbs2-0014" title="OhlJ , Bettahar LebugleK , RongieresC , AvrilC . Nitric oxide donors and in‐vitro fertilization. Human Reproduction2001;16(Suppl 1):22. OhlJ , Lefebvre‐MaunouryC , WittemerC , NisandG , LaurentMC , HoffmannP . Nitric oxide donors for patients undergoing IVF. A prospective, double‐blind, randomized, placebo‐controlled trial. Human Reproduction2002;17(10):2615‐30. ">Ohl 2002</a> compared glyceryl trinitrate (GTN) versus placebo. </p> </li> <li> <p><a href="./references#CD010001-bbs2-0002" title="AleyasinA , AghahosseiniM , MohseniM , MahdaviA . Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iranian Journal of Reproductive Medicine2009;7(4):175‐9. ">Aleyasin 2009</a> compared pentoxifylline + tocopherol vitamin E versus no treatment. </p> </li> </ol> </p> <p>Vasodilators probably make little or no difference in ectopic pregnancy rates compared with placebo or no treatment (RR 1.48, 95% CI 0.25 to 8.69; two RCTs; N = 250; I² = 5%; moderate‐quality evidence; <a href="./references#CD010001-fig-0012" title="">Analysis 1.6</a>; <a href="./full#CD010001-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> </section> </section> </section> <section id="CD010001-sec-0091"> <h4 class="title">Subgroup analyses</h4> <p>We did not conduct some analyses initially proposed as stratified because we found no suitable studies. </p> <p>As none of the included studies provided data on the number of women with endometrium measured as greater or less than 8 mm, we could not perform planned subgroup analyses. Only two studies mentioned that all women had a thin endometrium before interventions were provided (<a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>). </p> </section> <section id="CD010001-sec-0092"> <h4 class="title">Sensitivity analysis</h4> <p>Results of analysis did not change substantially when we excluded studies of vasodilators combined with another drug (vitamin E, oestrogen), or when we applied a random‐effects model. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010001-sec-0093" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010001-sec-0093">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010001-sec-0154">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010001-sec-0093"></div> <section id="CD010001-sec-0094"> <h3 class="title" id="CD010001-sec-0094">Summary of main results</h3> <p>Results of this systematic review suggest that moderate‐quality evidence is insufficient to show that vasodilators improve the live birth rate among women undergoing fertility treatment. However, treatment with vasodilators was associated with an increased overall rate of side effects compared with placebo or no treatment. Analysis of specific side effects revealed that headache and tachycardia were increased. </p> <p>Low‐quality evidence suggests that vasodilators alone or in combination with other treatments (vitamin E, oestradiol) increased clinical pregnancy rates compared with placebo or no treatment. When we excluded studies of vasodilators combined with other medications, we noted that vasodilators alone had similar effects on clinical pregnancy rates. </p> <p>Last, we found no clear evidence to suggest differences between groups for other adverse effects such as multiple gestation or birth, spontaneous abortion/miscarriage, and ectopic pregnancy; few relevant data were available. </p> </section> <section id="CD010001-sec-0095"> <h3 class="title" id="CD010001-sec-0095">Overall completeness and applicability of evidence</h3> <p>All studies reported pregnancy as an outcome. However, for women and for clinicians, live birth rate and side effects are the most important outcomes of fertility treatment. As only three studies and four studies reported these outcomes, respectively, this review might not address the main concerns surrounding fertility treatment. This, in turn, serves as evidence that more studies are needed to assess these important outcomes. No studies compared active interventions. </p> <p>Age restrictions for women specified in the inclusion and exclusion criteria of studies were similar across 11 included studies. However, some trials included women with a 'bad prognosis' (i.e. infertile women with a thin endometrium or with a history of two or more previous implantation failures), and other trials included women with a 'good prognosis' (i.e. women without a previous history of failure of zygote intrafallopian transfer (ZIFT) or in vitro fertilisation (IVF)). Even though we found no evidence of statistical heterogeneity in main outcomes among trials, we could not rule out the effects of clinical heterogeneity on study results. </p> <p>All studies compared the intervention versus placebo or no treatment, so a limitation of this review is that we found no head‐to‐head studies comparing two different vasodilators. </p> </section> <section id="CD010001-sec-0096"> <h3 class="title" id="CD010001-sec-0096">Quality of the evidence</h3> <p>Overall, the quality of evidence was low to moderate for most comparisons. The main limitations were imprecision due to low numbers of events and participants, and risk of bias due to unclear methods of randomisation and concealment of allocation, blinding, incomplete outcome data, and selective reporting. We could not assess risk of publication bias because of the small number of identified studies.<br/> <br/> We rated evidence for live birth and vasodilator side effects as moderate quality, with imprecision as the main limitation. Evidence for clinical pregnancy, multiple gestation, miscarriage and ectopic pregnancy, and vasodilator side effects was of low quality, with low precision and unexplained heterogeneity. Evidence for the thickened endometrium was of very low quality, and low precision and high heterogeneity are evident (<a href="./full#CD010001-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>Risk of selection bias was unclear in 10 studies. Concealment of allocation was adequate, and five trials explicitly described this. Five studies were placebo‐controlled but did not specify the use of blinding. Other studies were not blinded or failed to mention blinding. However, as most assessed outcomes were not subjective, lack of blinding did not imply an increase in risk of bias. Nine studies were analysed via intention‐to‐treat, five studies had unclear risk of attrition bias, and one study had high risk of attrition bias. Risk of selective reporting was unclear in some studies. Live birth rate was reported in a minority of cases, and only four studies reported adverse events as an outcome. </p> </section> <section id="CD010001-sec-0097"> <h3 class="title" id="CD010001-sec-0097">Potential biases in the review process</h3> <p>The process of identifying all potentially eligible studies for inclusion in this review was thorough and meticulous, even yielding three studies published only in abstract form. We contacted the authors of these works, but only one of them replied (<a href="./references#CD010001-bbs2-0005" title="DasV , AgarwalA , PandeyA , JainV , AgarwalS , AraA . Evaluation of role of sildenafil in improving IUI success rates. International Journal of Gynecology &amp; Obstetrics. 2009; Vol. 107S2 S413‐S729, issue Poster presentations. ">Das 2009</a>). Regarding all other procedures related to this review, we used the updated version of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, and, as far as possible, we adhered to methods specified in the protocol, so potential biases could be limited. Also, it was not possible to evaluate potential biases in all studies for lack of data. We considered these studies to have unclear risk of bias. We contacted the authors of these studies, but only two of them replied (<a href="./references#CD010001-bbs2-0009" title="FarziF , MehrafzaM , MirmansouriA , OudiM , HoseeiniA . Administration of NTG before embryo transfer does not increase pregnancy rate. Iranian Journal of Reproductive Medicine2005;3(2):95‐100. ">Farzi 2005</a>; <a href="./references#CD010001-bbs2-0010" title="KimKR , LeeHS , RyuHE , ParkCY , MinSH , ParkC , et al. Efficacy of luteal supplementation of vaginal sildenafil and oral estrogen on pregnancy rate following IVF‐ET in women with a history of thin endometria: a pilot study. Journal of Women’s Medicine2010;3(4):155‐8. ">Kim 2010</a>). </p> </section> <section id="CD010001-sec-0098"> <h3 class="title" id="CD010001-sec-0098">Agreements and disagreements with other studies or reviews</h3> <p>We have not reviewed other reviews in women undergoing assisted fertility treatment with vasodilators. However, we identified relevant studies in women undergoing assisted fertility treatment (<a href="./references#CD010001-bbs2-0054" title="FetihAN , HabibDM , AbdelaalII , HusseinM , FetihGN , OthmanER . Adding sildenafil vaginal gel to clomiphene citrate in infertile women with prior clomiphene citrate failure due to thin endometrium: a prospective self‐controlled clinical trial. Facts, Views &amp; Vision in ObGyn2017;9(1):21‐27. ">Fetih 2017</a>; <a href="./references#CD010001-bbs2-0025" title="SherG , FischJD . Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Human Reproduction2000;15(4):806‐9. ">Sher 2000</a>; <a href="./references#CD010001-bbs2-0082" title="SherG , FischJD . Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertility and Sterility2002;78(5):1073‐6. [PUBMED: 12413996] ">Sher 2002</a>; <a href="./references#CD010001-bbs2-0086" title="TakasakiA , TamuraH , MiwaI , TaketaniT , ShimamuraK , SuginoN . Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertility and Sterility2010;93(6):1851‐8. [PUBMED: 19200982] ">Takasaki 2010</a>). In a self‐controlled clinical trial, clinical pregnancy rate increased with sildenafil vaginal gel, but the numbers were small (<a href="./references#CD010001-bbs2-0054" title="FetihAN , HabibDM , AbdelaalII , HusseinM , FetihGN , OthmanER . Adding sildenafil vaginal gel to clomiphene citrate in infertile women with prior clomiphene citrate failure due to thin endometrium: a prospective self‐controlled clinical trial. Facts, Views &amp; Vision in ObGyn2017;9(1):21‐27. ">Fetih 2017</a>). Likewise, one of the most important observational studies was a cohort study examining the effect of vaginal sildenafil on the outcome of in vitro fertilisation after multiple IVF failures attributed to poor endometrial development; this study reported high ongoing pregnancy rates (<a href="./references#CD010001-bbs2-0082" title="SherG , FischJD . Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertility and Sterility2002;78(5):1073‐6. [PUBMED: 12413996] ">Sher 2002</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010001-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow of information through different phases of the systematic review." data-id="CD010001-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow of information through different phases of the systematic review.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010001-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010001-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p> Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.1 Live birth." data-id="CD010001-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.1 Live birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.2 Vasodilator side effects." data-id="CD010001-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.2 Vasodilator side effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.4 Clinical pregnancy." data-id="CD010001-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Vasodilator vs placebo or no treatment, outcome: 1.4 Clinical pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vasodilator vs placebo or no treatment, Outcome 1 Live birth." data-id="CD010001-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Vasodilator vs placebo or no treatment, Outcome 1 Live birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references#CD010001-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vasodilator vs placebo or no treatment, Outcome 2 Vasodilator side effects." data-id="CD010001-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Vasodilator vs placebo or no treatment, Outcome 2 Vasodilator side effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references#CD010001-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vasodilator vs placebo or no treatment, Outcome 3 Specific vasodilator side effects." data-id="CD010001-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Vasodilator vs placebo or no treatment, Outcome 3 Specific vasodilator side effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references#CD010001-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vasodilator vs placebo or no treatment, Outcome 4 Clinical pregnancy." data-id="CD010001-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Vasodilator vs placebo or no treatment, Outcome 4 Clinical pregnancy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references#CD010001-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vasodilator vs placebo or no treatment, Outcome 5 Thickened endometrium." data-id="CD010001-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Vasodilator vs placebo or no treatment, Outcome 5 Thickened endometrium.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references#CD010001-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010001-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/urn:x-wiley:14651858:media:CD010001:CD010001-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_t/tCD010001-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vasodilator vs placebo or no treatment, Outcome 6 Other adverse effects." data-id="CD010001-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Vasodilator vs placebo or no treatment, Outcome 6 Other adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references#CD010001-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/media/CDSR/CD010001/image_n/nCD010001-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010001-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vasodilator compared to placebo or no treatment for women undergoing fertility treatment</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Vasodilator compared to placebo or no treatment for women undergoing fertility treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> women undergoing fertility treatment<br/> <b>Setting:</b> secondary care<br/> <b>Intervention:</b> vasodilator<br/> <b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vasodilator</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Live birth</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>278 per 1000<br/> (196 to 398) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.18<br/> (0.83 to 1.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>350<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vasodilator side effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>109 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>256 per 1000</p> <p>(164 to 398)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 2.35</p> <p>(1.51 to 3.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>418</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> MODERATE<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>224 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>325 per 1000<br/> (267 to 397) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.45</p> <p>(1.19 to1.77)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1054<br/> (11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Thickened endometrium</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean thickness of the endometrium was 7.6 mm.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.11 mm higher<br/> (1.16 higher to 3.07 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>477<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,e</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Multiple gestation or birth</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 per 1000<br/> (36 to 158) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.15<br/> (0.55 to 2.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>370<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> LOW<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Spontaneous miscarriage</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000<br/> (26 to 128) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.83<br/> (0.37 to 1.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>350<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> LOW<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ectopic pregnancy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/> (4 to 140) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.48<br/> (0.25 to 8.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> LOW<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> CI: confidence interval; MD: mean difference; RCT: randomised controlled trial; RR: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded for Imprecision (‐1) as confidence interval is wide and the confidence interval includes the line of no effect. </p> <p><sup>b</sup>Downgraded for risk of bias (‐1) owing to unclear random generation sequencing and blinding of participants, personnel, and outcome assessor. </p> <p><sup>c</sup>Downgraded for risk of bias (‐1) owing to some studies having unclear risk and one trial having high risk of bias because of attrition. </p> <p><sup>d</sup>Downgraded for publication bias (‐1). The plot was asymmetrical owing to lack of small non‐significant published studies. </p> <p><sup>e</sup>Downgraded for Inconsistency (‐2) owing to high statistical heterogeneity (92%). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vasodilator compared to placebo or no treatment for women undergoing fertility treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/full#CD010001-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010001-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Vasodilator vs placebo or no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.83, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Glyceryl trinitrate (GTN) vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.69, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 PTX vitamin E vs no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.76, 2.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Vasodilator side effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.35 [1.51, 3.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Glyceryl trinitrate (GTN) vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [0.97, 4.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Sildenafil vs placebo or no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [0.91, 3.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Isosorbid mononitrate vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.3 [1.44, 7.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Specific vasodilator side effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Hypotension</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.58, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.12 [1.87, 9.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Tachycardia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.83 [1.25, 11.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Dizziness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.76, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.40 [0.96, 5.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Clinical pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1054</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [1.19, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Glyceryl trinitrate (GTN) vs placebo or no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Sildenafil vs placebo or no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.68, 3.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Sildenafil + oestrogen vs no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.84, 4.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 PTX + vitamin E vs no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.98, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 Amlodipine vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.67 [1.14, 11.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 Isosorbide mononitrate vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.8 [1.08, 7.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7 Tadalafil vs no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.08 [1.12, 3.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Thickened endometrium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [1.16, 3.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Isosorbid mononitrate vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.38, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Amlodipine vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.80 [0.66, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Sildenafil vs placebo or no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.61 [2.13, 3.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Tadalafil vs no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.57 [3.01, 4.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Other adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Multiple gestation or birth: NTG or isosorbide mononitrate vs placebo and PTX + tocopherol vs no treatment </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.55, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Spontaneous abortion/miscarriage NTG vs placebo and PTX + tocopherol vs no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.37, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Ectopic pregnancy: NTG vs placebo and PTX + tocopherol vs no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.25, 8.69]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Vasodilator vs placebo or no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010001.pub3/references#CD010001-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010001.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010001-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010001-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010001-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD010001-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD010001-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010001-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010001\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010001\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010001\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010001\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010001\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xsb6SJyC&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010001.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010001.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010001.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010001.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010001.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727501860"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010001.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727501864"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010001.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ead9eef3cf573',t:'MTc0MDcyNzUwMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 